JPH0326616B2 - - Google Patents
Info
- Publication number
- JPH0326616B2 JPH0326616B2 JP60149101A JP14910185A JPH0326616B2 JP H0326616 B2 JPH0326616 B2 JP H0326616B2 JP 60149101 A JP60149101 A JP 60149101A JP 14910185 A JP14910185 A JP 14910185A JP H0326616 B2 JPH0326616 B2 JP H0326616B2
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- bone
- reconstituted
- preparation according
- purified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000008186 Collagen Human genes 0.000 claims description 170
- 108010035532 Collagen Proteins 0.000 claims description 170
- 229920001436 collagen Polymers 0.000 claims description 158
- 210000000988 bone and bone Anatomy 0.000 claims description 132
- 230000007547 defect Effects 0.000 claims description 67
- 238000002360 preparation method Methods 0.000 claims description 50
- 230000008439 repair process Effects 0.000 claims description 37
- 239000000843 powder Substances 0.000 claims description 23
- 102000004142 Trypsin Human genes 0.000 claims description 16
- 108090000631 Trypsin Proteins 0.000 claims description 16
- 239000012588 trypsin Substances 0.000 claims description 16
- 239000000725 suspension Substances 0.000 claims description 14
- 230000002500 effect on skin Effects 0.000 claims description 11
- 102000035195 Peptidases Human genes 0.000 claims description 8
- 108091005804 Peptidases Proteins 0.000 claims description 8
- 239000000835 fiber Substances 0.000 claims description 7
- 244000309466 calf Species 0.000 claims description 6
- 102000057297 Pepsin A Human genes 0.000 claims description 4
- 108090000284 Pepsin A Proteins 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 229940111202 pepsin Drugs 0.000 claims description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims 1
- 235000011613 Pinus brutia Nutrition 0.000 claims 1
- 241000018646 Pinus brutia Species 0.000 claims 1
- 238000005266 casting Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 41
- 239000000501 collagen implant Substances 0.000 description 37
- 238000000034 method Methods 0.000 description 35
- 239000000463 material Substances 0.000 description 21
- 238000009472 formulation Methods 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 16
- 239000007943 implant Substances 0.000 description 12
- 241000283690 Bos taurus Species 0.000 description 11
- 229940036811 bone meal Drugs 0.000 description 11
- 239000002374 bone meal Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 230000008569 process Effects 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 230000008468 bone growth Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 230000029087 digestion Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 8
- 108700005457 microfibrillar Proteins 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 239000000512 collagen gel Substances 0.000 description 6
- 238000002513 implantation Methods 0.000 description 6
- 238000001471 micro-filtration Methods 0.000 description 6
- 230000002188 osteogenic effect Effects 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 6
- 210000003625 skull Anatomy 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 210000002449 bone cell Anatomy 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 210000001724 microfibril Anatomy 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 230000011164 ossification Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 210000004409 osteocyte Anatomy 0.000 description 4
- 210000004761 scalp Anatomy 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000000890 antigenic effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000005251 gamma ray Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000005847 immunogenicity Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 239000008215 water for injection Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 2
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 241000906034 Orthops Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000005875 antibody response Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229940112869 bone morphogenetic protein Drugs 0.000 description 2
- 230000010478 bone regeneration Effects 0.000 description 2
- 239000000316 bone substitute Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 150000001945 cysteines Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 210000005009 osteogenic cell Anatomy 0.000 description 2
- 210000004663 osteoprogenitor cell Anatomy 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 210000002379 periodontal ligament Anatomy 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 description 1
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 101710167839 Morphogenetic protein Proteins 0.000 description 1
- 208000006670 Multiple fractures Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 238000003811 acetone extraction Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000010256 bone deposition Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 239000000515 collagen sponge Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 210000004262 dental pulp cavity Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 210000003275 diaphysis Anatomy 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- -1 glycosamino-glycan Chemical class 0.000 description 1
- 210000004349 growth plate Anatomy 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000012931 lyophilized formulation Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000004373 mandible Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000005088 multinucleated cell Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 210000003455 parietal bone Anatomy 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009589 serological test Methods 0.000 description 1
- 231100001055 skeletal defect Toxicity 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 239000007966 viscous suspension Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æè¡åé
æ¬çºæã¯èæ€åç©ãç¹ã«åºä¹³åç©åã³äººéã®éªš
ã®ä¿®åŸ©ã«é¢ãããããã«è©³ããã¯ãæ¬çºæã¯ã³ã©
ãŒã²ã³ãåºç€ãšãã移æ€ææãçšããŠéªšã®äŒå°ã«
ããè£ä¿®ãä¿ã骚ã®ä¿®åŸ©æ¹æ³ã«é¢ããããã®ã³ã©
ãŒã²ã³ææã¯é«åºŠã«ç²Ÿè£œãããéå ç«æ§ã®ãã®ã§
ãããæãŸããå Žåã¯ã被移æ€äœãšç°ãªãçš®ã«å±
ãããã®ã§ãè¯ãããã®ã³ã©ãŒã²ã³ã¯ãç®èåã¯
骚ç±æ¥ã®ææåã¯ãããã®æ··åç©ããã®åæ§ææ
æã§ããã æè¡çèæ¯ïŒœ æ¬ é¥ã®ãã骚ã®ä¿®åŸ©ã¯äœäžçŽã«ãäºã€ãŠäººé¡ã
æ©ãŸããŠããåé¡ã§ãããæ¯èŒçæè¿ãŸã§ã¯æã
ã骚ãåºå®ã骚çµç¹ãæå·éšã«èªç¶ã«åçé·ãã
ã®ã«é Œãã®ãå¯äžã®å®çšçãªæ¹æ³ã ã€ããã ãã
ãããå€ç§æè¡ã®é²æ©ã«ãã€ãŠã移æ€ãã骚代çš
ç©ãæå·ãåãã骚ãç æ°ã®éªšæ§é äœã®è£å¡«ã®ã¿
ãªãããéªšæ Œæ§é äžã®å 倩çåã³åŸå€©çãªæ¬ é¥ã®
修埩ã«ããå©çšã§ããããã«ãªã€ãã ãã以æ¥ãåºç¯ãªææãå©çšãããéªšå šäœãäŸ
ãã°è¡é¢ç¯éšïŒç±³åœç¹èš±ç¬¬3820167å·ïŒãæ¯ïŒç±³
åœç¹èš±ç¬¬4186486å·ïŒã眮æããããã®ç²ŸåŠãªæ¹
æ³ãé瀺ãããŠããã䜿çšãããææã®äžã«ã¯ã
ãã¿ããŠã ïŒEPå ¬é0071242ã1983幎ïŒæïŒæ¥ïŒ
ç±³åœç¹èš±ç¬¬3918100å·ïŒçã®éå±é¡ãé žåã¢ã«ã
ããŠã ïŒç±³åœç¹èš±ç¬¬3919723å·ïŒçã®ã»ã©ããã¯
é¡ãæ圢ãããã¯åŠçãã骚ïŒç±³åœç¹èš±ç¬¬
3318774ïŒãåã³äŸãã°å¯ææ§ã®ãããç¶ã«å§çž®ã
ã骚ç²ïŒç±³åœç¹èš±ç¬¬2621145å·ïŒçã®çš®ã ã®éªšè£œ
å€ãããã éªšæ Œçµç¹ãç¡æ©æåãšææ©æåãå«ãããšã¯å€
ãããç¥ãããŠãããæããã¯éªšæ§é ã®åŒ·åºŠãšç¡¬
ããæ ã€ãŠããç¡æ©æåã®å€§åã¯ãªã³é žã«ã«ã·ãŠ
ã ãã€ãŸãããããã·ã¢ãã¿ã¿ã€ãã®åœ¢ã§ååšã
ãããŸããææ©æåã¯äž»ãšããŠåäžã®çš®é¡ã®èçœ
質ãã€ãŸãã³ã©ãŒã²ã³ããæ§æãããããã¯åŒŸæ§
ãä¿æããŠéªšæ§é ãäžåœã«ããããªãã®ãé²æ¢ã
ãŠããããã¡ããéªšæ Œçµç¹ã¯çããŠããã®ã§ã骚
æ§é äžã«ã¯ä»£è¬æŽ»æ§ã®ããä»å çãªææ©æåãå
åšããªããã°ãªããããããã骚现èããã®æŽ»æ§
ãªä»£è¬ç©ãèªç¶æ²»çéçšãæ²»çã®ç¶æéçšã«å¯äž
ããŠããã ããããªããã骚ã®äž»æåã¯éçã«ã¯ã³ã©ãŒã²
ã³ãšã»ã©ããã¯ãªã®ã§ãåæ§ã®åã¯ç°ãªãã»ã©ã
ãã¯ææ䞊ã³ã«çš®ã ã®åã®ã³ã©ãŒã²ã³è£œå€ãå«ã
å€æ§ãªåæ§æã«ç§»æ€ç©ã䜿çšãããŠãããäŸã
ã°ãæïŒHayashiãK.ãet alãArc Orthop
Traumat SurgïŒ1982ïŒ99ïŒ265ãåã³ç±³åœç¹èš±ç¬¬
4314380å·ïŒãåç §ã®äºã 骚ã®ä¿®åŸ©ã¯æ¬¡ã®äºã€ã®ãã¡ã®ããããã®æ©æ§å
ã¯ããããçµã¿åããã€ãæ©æ§ã§èµ·ããããšãå€
ã€ãŠãããããªãã¡ãäŒå°ä¿®åŸ©
ïŒconductiverepairïŒã«ãããŠã¯æ¢ã«éªšçŽ°èãšã
ãŠã®ç¹æ§ãåãã现èïŒå骚现èïŒãè¿æ¥ãã骚
ããæ¬ é¥éšã®ç©ºéã«ç§»åãçŽæ¥éªšã圢æãããã
ã®å Žåã¯ïŒéç¹ç°çãªæ é€çŽ 以å€ã¯ïŒäœçç¹å¥ãª
å åã¯å¿ èŠãšããªããããããªãããèªå°ä¿®åŸ©
ïŒinduction repairïŒã«ãããŠã¯ãã®éçšã®åã«ã
ååããŠããªãè€æ°ã®å¯èœæ§ãæã€ã现èã®å骚
现èãžã®å€æããªããããå骚现èã¯å ãè»éªšã
圢æãããããç³ç°åãããŠå€è³ªã骚ã«å€ããã
ãã®æ§ã«ããèœåãåŸãããã«ã¯ç¹å®ã®èçœè³ªå
åãå¿ èŠãšããããããã®å åã®æ§è³ªã¯çŸæç¹ã§
ã¯ç解ãããŠããªããäŒå°ä¿®åŸ©ãèªå°ä¿®åŸ©ã®ãã
ãã«ã€ããŠãã宿䞻ã®çäœçµç¹ããæçµçãªéªšæ Œ
çµç¹ãæäŸãããå¿ èŠããããåŸã€ãŠããããã
éçšãåªä»ãã移æ€ç©ã¯ãæ¬ é¥ã®ãã骚ãé€å»ã
ãã骚ã®ä»£æ¿ç©ãšããŠåãã®ã§ã¯ãªãããããæ¬
ããŠããçµç¹ã®åçã掻æ§åããããã®åºè³ªçæ¯
æäœãšããŠåãã åŸã€ãŠããŸãã«ããããããšãç®çãšããŠãæ¬
é¥ã®ããéªšæ Œçµç¹çšåã¯éªšãæ¯ã®ç å·£çšã®ç§»æ€ç©
ãèæ¡ããè©Šã¿ããªãããŠããããããã®ç§»æ€ç©
ã¯æ¬ ããŠãã骚ã®çµæãæš¡å£ãããã®ã§ã¯ãªã
ãŠãæ§é çãªæ¯æäœãåã³æçµçã«é£æ¥ããæ°é®®
ãªéªšããçãã骚ã®æ²çç©ãåŸã ã«äŸµå ¥ãããæ¡
å åºè³ªãšããŠåããããããæ¯æäœã¯åã«åºè³ªç
æ¯æäœãšããŠã®æ©èœãæäŸããïŒã€ãŸããäŒå°ä¿®
埩ãåªä»ããïŒã ãã§ãªããçŸåšã骚圢æå åã
ïŒOFïŒåã¯ã骚圢æ çºçèçœè³ªãïŒBMPïŒãšããŠ
ç¥ãããŠãããã®ãä»äžããããšã«ãã€ãŠããã
ã«æªååã®çŽ°èã®å骚现èãžã®ååãä¿ãå åã
å«ãå Žåããããã³ã©ãŒã²ã³ã¯éªšã®æé·ã«äŒŽã代
è¬çã«çåå¯èœãªçŽ°èäžã§æ¢ã«è¯ãç¥ãããç©è³ª
ãªã®ã§ãèªå°ç骚修埩åã³äŒå°ç修埩ã®ãããã®
ç®çã®ããã«ãã倧éšåãã³ã©ãŒã²ã³ããæã移
æ€ç©ã䜿çšããè©Šã¿ããªãããŠããã èªå°ä¿®åŸ©ã«æçšãªç§»æ€ç©ã«ã€ããŠã¯ãç±³åœç¹èš±
第4294753ã«éªšåœ¢æ çºçèçœè³ªã®è£œé æ¹æ³ãé瀺
ãããŠãããæããåè¿°ã®ç¹èš±ã®BMPãšã¯ç°ãª
ããOFã®ç²Ÿè£œæ¹æ³ãç±³åœç¹èš±ç¬¬4434094å·ïŒ1984
幎ïŒæ28æ¥çºè¡ïŒã«é瀺ãããŠããããããã®å
åã¯éªšäžã䞊ã³ã«ç§»æ€çã®è£œé ã«äœ¿çšããæãã
ã¯ãã®å åãæå¹ãªåœ¢ã§æŸåºãããç¡æ©æåãé€
å»ãã骚ã®ç²å補å€äžã«å€©ç¶ã«ååšãããããã
ã®å åã¯ç²Ÿè£œåã³æªç²Ÿè£œã®åœ¢ã§å€ãã®ç§»æ€çã«äœ¿
çšãããŠããã ãŸããäŒå°ç骚修埩掻æ§ã®ããã®åºè³ªãšããŠã
ããªãã¡å现èã骚çºç现èã«æçãããããã®
å åãå«ãŸãåŸã€ãŠäŒå°ä¿®åŸ©ãåªä»ãã補å€ãšã
ãŠãã³ã©ãŒã²ã³è£œå€ã®ã¿ãå©çšããããšããè©Šã¿
ã«ã€ããŠé瀺ããç 究è ãããã ã¯ã¬ã±ã©ãŒïŒKrekelerãV.G.ãet alãJ.Oral
SurgïŒ1981ïŒ10ïŒSuppl.1ïŒ151ïŒã¯èªå·±ç±æ¥ã®æµ·
綿質ãã³ã©ãŒã²ã³è£œå€ïŒã³ã©ãŒã²ã³ããªãŒã¹ïŒå
æšåããã³ã¿ãã¢ãŒã 瀟ïŒãåã³çµåæ§ãŒã©ãã³
ã«ã€ããŠããŒã°ã«ç¬ã®æ¯æ ¹èæ¬ é¥çšå å¡«ç©ãšããŠ
ã®æå¹æ§ãæ¯èŒããããããã®è£œå€ã¯äººå·¥çã«èš
ãã骚ã®ç©ºæŽäžã«å·£ã«å å¡«ããççéçšãããªã¯
ãã é次ã©ããªã³ã°ã§è¿œè·¡ãããã³ã©ãŒã²ã³ããª
ãŒã¹ã¯ççãåªä»ããããšãå€ã€ãããèªå·±ç±æ¥
ã®æµ·ç¶¿è³ªç§»æ€çã«æ¯èŒãããšå¹æãå°ããã€ãã äžè¿°ã®è£œå€ã§çšããã³ã©ãŒã²ã³ããªãŒã¹ã¯è±ã®
ç®èããç±³åœç¹èš±ç¬¬4066083å·ã«é瀺ã®æ¹æ³ã«åŸ
ã€ãŠè£œé ãããã®ã§ãããè±ã®ç®èã现ããåå²
ããæŽå€ã§è±èåŸæŽæµããã次ãã§ããã·ã³ã§æ¶
åããŠç²çš ãªæžæ¿æ¶²ãšã飜å塩溶液ãå ããŠã³ã©
ãŒã²ã³ãæ²æ®¿ãããããã®æ²æ®¿ç©ãé žäžã«æžæ¿ã
ãåŸã塩溶液äžã«ç¹ç¶ç¶ã®çœè²æ²æ®¿ç©ãšããŠåæ²
殿ããããæ²æ®¿ç©ãå¿ èŠãªåæ°æŽæµããŠããã¢ã«
ã³ãŒã«æŽæµããŠè±å¡©ããã粟補ã³ã©ãŒã²ã³ãé žæº¶
液äžã«æžæ¿ããåçµä¹Ÿç¥ããããããγç·ç §å°ã§
æžèãããããã®å·¥çšã§è£œå€ãå£åãæ¶æ©ããå Ž
åãããããã®è£œå€ã¯ã³ã©ãŒã²ã³ããªãŒã¹
ïŒCollagen fleeceïŒã®å称ã§åžè²©ãããäœä»¶ãã®
ä»ã®éªšã®ä¿®åŸ©ã®ç 究ã«äœ¿çšãããŠããã ãžãšãŒãºçïŒJoosãU.ãet alãBiomaterials
ïŒ1980ïŒïŒïŒ23ã26ïŒã³ã©ãŒã²ã³ããªãŒã¹ã人工
çã«å·ã€ãããŠãµã®ã®äžé¡éªšã®ç§»æ€çãšããŠå©çš
ããïŒé±éåŸã«æ¬ é¥ã網ç¶ã®éªšç²ã§æºããããïŒ
é±éåŸã«ã¯å®å šã«éªšåããããšãèŠåºããããŒã
ããã³çïŒZetzmannãD.ãet alãSchweiz
Mschr SabnhelikïŒ1982ïŒ92ïŒ119ïŒãã³ã©ãŒã²
ã³ããªãŒã¹ã移æ€çãšããŠçšããŠé¡é¢å€ç§ã«ãã
ã骚ã®åçã«æåãããã¹ããªã³ãŽã©ã ç
ïŒSpringorumãH.W.ãet alãZ.OrthopïŒ1977ïŒ
115ïŒ686ïŒã¯ã³ã©ãŒã²ã³ããªãŒã¹ãç®è³ªå±€ã®æ¬ é¥
ã«çšããŠåæ§ã®çµæãåŸãã ãžã€ãã€çïŒJaffeeãA.ãet alãArchs Oral
BiolïŒ1978ïŒ23ïŒ415ïŒibid.ïŒ1982ïŒ27ïŒ999ïŒã¯ç¬
ã®ç®èããé ¢é žæœåºãããªã¯ããé ¢é žïŒãšã¿ããŒ
ã«ã§ç²Ÿè£œããŠè£œé ããã³ã©ãŒã²ã³æº¶æ¶²ã䜿ã€ãŠã
ç¬ã«ãããã¢ã¯ãªã«é žæš¹èæ¯ç§»æ€çã®åºå®ã«æå
ããããšãå ±åããŠãããåºå®ã«æåãã移æ€ç
ã¯ïŒå¹ŽåŸã«ãæãããªãã€ãã ã¯ãŠã·ã³çïŒCucinããL.ãet alãNew
York State Journal of MedecineïŒ1979ïŒ1856ïŒ
ã¯ãγç·ç §å°ãããåçã®ç®èããã®ã¢ãããã
ããã»ã³ã©ãŒã²ã³ããŠãµã®ã®å©éªšã®ä¿®åŸ©ã«äœ¿çšã
ãããŸãããŒã©ãã³ç¶ã¹ãã³ãžææåã¯èªå·±ç±æ¥
ã®éªšç²ã§æ¯æããŠãç¬ã®é èã®ç©Žã®ä¿®åŸ©ã«äœ¿çšã
ãã æãããããããããå«ãã ãŸãŸã§ãγç·ç §å°
ã«ããæ¶æ©ããã³ã©ãŒã²ã³è£œå€ã®æ¯é«è ã®å å¡«å
ã³ç®äžã骚代çšã移æ€çãšããŠã®å©çšããããã
ãEPå ¬é0012443ïŒ1980幎ïŒæ25æ¥ïŒåã³EPå ¬é
0012959ïŒ1980幎ïŒæïŒæ¥ïŒã§é瀺ãããŠããã 解決ãã¹ãåé¡ç¹ïŒœ äžè¿°ã®ã³ã©ãŒã²ã³ä¿®åŸ©æ¹æ³ã¯ããããå®å šã«ã¯
æåããŠããããççãèµ·ãããïŒç¹ã«è¢«ç§»æ€éš
ãšç°çš®ã®ã³ã©ãŒã²ã³ãçšããå ŽåïŒççãäžå®å š
ã ã€ãããããæ¬çºæã¯äžè¿°ã®æ¬ ç¹ã解æ¶ããã
ãšãåºæ¬ç®çãšããå æ¹ã«æé·ãã骚修埩çµç¹
ããæå®ã®éªšçŽ°èãã修埩ãæãŸããæ¬ é¥ã«äŒé
ãåŸã移æ€å¯èœãªã³ã©ãŒã²ã³è£œå€ãæäŸããããš
ã課é¡ãšããã çºæã®é瀺 æ¬çºæã¯ã被移æ€éšãšã¯ç°çš®ã®ã³ã©ãŒã²ã³ã䜿
çšå¯èœãªãããå€éã«å ¥æããããšãã§ãã極ã
ãŠå¿çšæ§ãåºããããã«ãæ¬çºæã¯èå¿åæ§ãèŠ
æ±ãããåºç¯å²ã®çšéã«å¯ŸããŠæ¥µããŠé©çšæ§ãé«
ãã æ¬çºæã¯æ¬ é¥ã«ãïŒå¿ èŠã§ããã°ïŒä¿®åŸ©ããã
åŽãšã¯ç°çš®ã®çç©ããåŸãã粟補éå ç«åæ§ã³ã©
ãŒã²ã³ã移æ€ããããšã«ãã€ãŠåºä¹³é¡ïŒç¹ã«äºº
éïŒã®éªšã®æ¬ é¥ã修埩ããããéªšæ Œåºè³ªãåçã
ããããããã®ã³ã©ãŒã²ã³è£œå€ãæäŸãããåŸã€
ãŠãæ¬çºæã¯é«åºŠã«ç²Ÿè£œãããæ°ãã骚ã®çé·ã®
ããã®åºè³ªãæäŸãåŸãæ±çšã³ã©ãŒã²ã³è£œå€ã䜿
ã€ãŠçäœçµç¹ã®éªšã®æ¬ é¥ã®èªç¶ãªä¿®åŸ©æ©æ§ãåªä»
ããæ¹æ³ãæäŸããã æ¬çºæã«ãããŠã¯ãçããŠããå骚现è
ïŒosteoprogenitor cellïŒãå«ãæ°é®®ãªéªšãæ¬ é¥éš
ã«é²åºããããã骚åã³ç®èã®ããããåã¯äž¡æ¹
ããåŸãçµæç©ã§ããã³ã©ãŒã²ã³è£œå€ãšæ¥è§Šãã
ãã骚起æºã®ã³ã©ãŒã²ã³ã¯ç¡æ©æåãé€å»ãã骚
ïŒDMBïŒãã補é ãããããããããäºå®äžé€
å»ããåããå®è³ªçã«æ§æããããããã¯ãèª
å°ä¿®åŸ©ãåªä»ããå åãç Žå£ãããã€ããããã
ããé€å»ããããªãã·ã³çã®ã³ã©ãŒã²ã³éå解æ§
ã®èçœè³ªåè§£é µçŽ ã§DMBãåŠçããŠè£œé ããã
ãã®ç©è³ªã¯ç²æ«ç¶ã§åŸããã骚ã³ã©ãŒã²ã³ç²æ«
ïŒBCPïŒãšèšããç®èèµ·æºã®ã³ã©ãŒã²ã³ã¯äž»ãšã
ãŠåã³ã©ãŒã²ã³ã§å°éã®åãå«ã¿ãå žåçã«
ã¯åçã®ç®èããåŸãããããã®åã®ã³ã©ãŒã²ã³
ã¯ã¶ã€ããŒã ïŒZydermãåæšåïŒã³ã©ãŒã²ã³ç§»
æ€ç©ãšããå称ã§åžè²©ãããŠãããZCIãå žåãš
ãããã®ã³ã©ãŒã²ã³è£œå€ã¯åæ§æããã埮ç¹ç¶ç¶
ã®ã¢ããããããã³ã©ãŒã²ã³ã§ãããããã«ãç®
èèµ·æºã®ã³ã©ãŒã²ã³è£œå€ã¯ç§»æ€ããåã«åçµä¹Ÿç¥
ããããšãã§ããã ãããã®ããããã®æ··åç©ã®BCPãšZCIã®æ¯ã
å€åãããããšã«ãã€ãŠä¿®åŸ©ææã®ç©æ§ã調ç¯
ããæ¬ é¥ã®ç¹å®ã®èŠæ±ãåšå²ç°å¢ã«é©å¿ãããã
ãšãã§ããã åŸã€ãŠæ¬çºæã¯äžã€ã®èŠç¹ã«ãããŠã(a)çããŠ
ããå骚现èãæããæ°é®®ãªéªšã®è¡šé¢ãæ¬ é¥éšã«
é²åºãã(b)åèšæ¬ é¥éšã«ã³ã©ãŒã²ã³è£œå€ãå å¡«ã
æ°é®®ãªéªšã®è¡šé¢ãšæ¥è§Šãããããšããæã骚ã®æ¬
é¥ã®ä¿®åŸ©æ¹æ³ã«é¢ãããåèšã³ã©ãŒã²ã³è£œå€ã¯ç²Ÿ
補åæ§æã¢ãããããã埮ç¹ç¶ç¶ç®èã³ã©ãŒã²ã³
åã¯éªšã³ã©ãŒã²ã³ç²æ«ïŒåèšããå®çŸ©ã®éãïŒã
æãã¯ãããã®æ··åç©ã§ããã 粟補åæ§æ埮ç¹ç¶ç¶ã³ã©ãŒã²ã³ã¯åçµä¹Ÿç¥äœã§
ãè¯ãããã®åçµä¹Ÿç¥è£œå€ïŒåçµä¹Ÿç¥ã³ã©ãŒã²ã³
ã²ã«åã¯LCGïŒã¯åãæ±ãæãå§å»¶ãããã¯æ³š
åããŠæ¿ç¶ã«ããããšãã§ããããã¯å®¹æã«ç§»æ€
ç©ïŒçïŒãšããŠå©çšã§ããã ç®èèµ·æºã®ã³ã©ãŒã²ã³ã¯å žåçã«ã¯ç®èããã
å¯æº¶å圢æ ãžã®è§£é¢ããéã«ããæ» èãåã³ãã
ããããé€å»åŸã®åŸ®ç¹ç¶åœ¢æ ãžã®åæ§æãšããå·¥
çšãçµãŠè£œé ããã代衚çãªè£œå€ã¯è»éšçµç¹ã®ä¿®
埩ã«æçšã ãšèšèŒãããŠããããã®ç®çã®ããã«
ã¶ã€ããŒã ã»ã³ã©ãŒã²ã³ç§»æ€ç©ïŒZCIïŒã®åã§åž
販ãããŠãããããã®è£œé æ¹æ³ã¯ç±³åœç¹èš±ç¬¬
3949073å·ã«è©³çŽ°ã«èšèŒãããŠããã 骚ã³ã©ãŒã²ã³ç²æ«ã¯ç¡æ©æåãé€å»ãã骚
ïŒDMBïŒããåŸãããå®è³ªçã«ããããããã
ãé€å»ãããåã³ã©ãŒã²ã³ããæããããã¯
DMBãããªãã·ã³ã§åŠçããŠè£œé ãããããªã
ã·ã³ã¯éªšåœ¢æåã³ããããããã«é¢é£ããå åã
å ±ã«ç Žå£ããããã®æ¹æ³ã«ãã€ãŠåŸããã骚ã³ã©
ãŒã²ã³ç²æ«ïŒBCPïŒã¯äžè¿°ã®å¥œãŸããæ§è³ªãšå ±
ã«èå¿åæ§ãæããéªšæ Œã®æ¬ é¥çšã®è² è·æ¯æäœãš
ãªãã æ¬çºæã¯å¥ã®è«žèŠç¹ã«ãããŠã¯ãæ¬çºæã«æçš
ãªã³ã©ãŒã²ã³è£œå€åã³ãã®è£œé æ¹æ³ã«é¢ããã çºæã®å®æœæ æ§ïŒœ  å®çŸ© æ¬æ现æžã«ãããŠã骚ã®æ¬ é¥ã®ãäŒå°ã
ïŒconductiveïŒä¿®åŸ©ãšã¯æ¬ ããŠãã骚ãè£å ã
ããéçšåã¯ææã®æ°ãã骚ãæé·ããéçšã®
ããšãèšããåºãæ什ãåããïŒcommittedã
å³ã¡ååããïŒå骚现èïŒosteoprogenitor
cellïŒã®ä»£è¬ãå«ãããããã®çŽ°èã¯ãäžè¬ã«
骚圢ææ§åã¯åœ¢æ çºçæ§èçœå åãšããŠç¥ãã
ãèçœå åã«ããèªå°ãªãã«è»éªšåã³ïŒåã¯éªš
ãçæããããšãã§ãããã®éçšã¯ååãã现
èã«ãã€ãŠéªšåœ¢çãçŽæ¥çã«è¡ãããæ©èœãå«
ãããååãã现èã®çæã«èçœå åã®æ·»å ã¯
å¿ èŠãšããªãã æªååã®çŽ°èã®å骚现èãžã®å€åã¯çäœã«åº
æã®èçœè³ªã«ãã€ãŠãè¡ããåŸãããšã¯ç解ã
ãããããããããã§å®çŸ©ãããäŒå°æ§ã骚修
埩ã¯å€éšããäŸçµŠãããæ¯æåºè³ªã®ã¿ã«ãã€ãŠ
åªä»ããããã®ã§ãç°çš®ã®çäœçµç¹ãéå åšç
ãªéªšåœ¢æå åã¯æäŸããªãã ã骚ã®æ¬ é¥ããšã¯éªšçµç¹ã®ä»çãæãŸãã骚
æ Œçµç¹ã®ééã®ããšã§ããã®ééã¯çäœã«å¯Ÿã
ãå·å®³ãããã¯çäœã®éªšæ Œçµç¹ã®å 倩æ§ç°åžžå
ã¯å£åã«ãã€ãŠçãããããããæ¬ é¥ã¯åãªã
骚æãç æ°ã«ãã骚çµç¹ã®åŽ©å£ãç æ°ã®éªšçµç¹
åã¯æãŸãããªãå 倩æ§ç°åžžã®å€ç§çãªé€å»ã
æãã¯æŽåœ¢å€ç§åã¯çŸå®¹å€ç§ã®çµæãšããŠçã
ãããšãããã ãæ°é®®ãªéªšããšã¯å¥åº·ãªç¶æ ã«ãããåéã
ãŠçäœçµç¹ãé²åºããããšçã«ãã€ãŠåŠçãã
ãçäœçµç¹ã®éªšæ Œç³»äžã®éªšã®ããšãèšããæ¬çº
æã®æ¹æ³ã«ãããŠæ¬ é¥éšã®éªšã®åççšã«çããŠ
ãã现èãæäŸããããã«ã¯ãæ°é®®ãªéªšãæ¬ é¥
éšã«æ¥è§Šãããå¿ èŠãããããšãå€ã€ãŠããã ãã³ã©ãŒã²ã³è£œå€ããšã¯äž»æåãšããŠããçš®
ã®ã³ã©ãŒã²ã³èçœè³ªãå«ãçµæç©ãèšãã ãç°çš®ã®ãïŒxenogeneicïŒãšã¯æ²»çãããç
äœäžã®çš®ïŒspeciesïŒãšã¯ç°ãªãçš®ã«ã€ããŠèš
ãã ãäžçŽç©ãå«ãŸãªããåã¯ã粟補ãããããš
ã¯èªç¶ç¶æ ã§ã³ã©ãŒã²ã³çã®è£œå€äžã«é垞䌎ã
ããäžçŽç©ã®ååšããªãããšãèšããããªã
ã¡ãåçã®ç®èãã調補ããã³ã©ãŒã²ã³ã¯ãå
çã®ç®è以å€ã®æåãå®è³ªçã«é€å»ããŠããŸã
ã°äžçŽç©ãå«ãŸãã骚ããã®ã³ã©ãŒã²ã³è£œå€ã«
ã€ããŠèšãã°éªšä»¥å€ã®æåãé€å»ããã°äžçŽç©
ãå«ãŸãªãããšã«ãªãã ãåæ§æïŒreconstitutedïŒãã³ã©ãŒã²ã³ãšã¯
ïŒæ¬ãããç¶ã®ååããããããã䌞é·éšãä»
ããç¶æ åã¯ä»ããŠããªãç¶æ ã§å¥ã ã«åé¢ã
ãŠæº¶æ¶²äžã«å°å ¥ãã次ãã§åŸ®ç¹ç¶ç¶
ïŒfibrillarïŒã«åæ§æããã³ã©ãŒã²ã³ã®ããšã
èšãããã®åœ¢ç¶ã«ãããŠåŸ®ç¹ç¶ã¯çŽ°é·ãã³ã©ãŒ
ã²ã³ååããæããçžäºã«ããããç¶ã«éãªã
åã€ãŠé·ãã®çŽ1/4ã®å¹ ãæããããã®çµæã
垯ç¶æ§é ããªããããã«åéããŠç¹ç¶ç¶ã«ãªã
ããšãã§ããã ãå®è³ªçã«æ¶æ©ããªãããšã¯ããããããã
é€å»ãæ¬æ¥ã®æ¶æ©åœ¢æèœåãæ¬ ã補å€ãšããã³
ã©ãŒã²ã³ã«ã€ããŠããããã®æ§ãªè£œå€ã¯ãäŸã
ã°ã°ã«ã¿ã«ã¢ã«ãããåŠçããããããããçµ
åã®æ¬äŒŒçãªåœ¢æ ã圢æãããããªåŠçãè¡ã
ããšã«ãã€ãŠæå³çã«æ¶æ©ãããªãéãå®è³ªç
ã«æ¶æ©ããªããäŸãã°é«æž©ãγç·ç §å°çã®æ» è
ãç®çãšããŠãã°ãã°è¡ãããåŠçã«ãããã
ããç¶ååéã«ä»å çã«æ¶æ©ã圢æããããæ¬
çºæã«äœ¿çšããã補å€ã§ã¯ãç®èèµ·æºã®ã³ã©ãŒ
ã²ã³ã溶液äžã«åæ£ãããŸãŸã®ç¶æ ã§åŸ®çŽ°ãé
ïŒmicrofiltrationïŒããŠæ» èããåŸæ» èæ¡ä»¶äž
ã§åŠçããã®ã§æãŸãããªãæ¶æ©ã®åœ¢æãåé¿
ãããã ã骚ã³ã©ãŒã²ã³ç²æ«ãïŒBCPïŒãšã¯ç¡æ©æå
ãé€å»ãã骚起æºã®ã³ã©ãŒã²ã³ã®ç²Ÿè£œã¢ããã
ããã補å€ãèšãããã®è£œå€ã¯å®è³ªçã«ã³ã©ãŒ
ã²ã³èªäœããæãã代è¬çã«æŽ»æ§ãªèçœè³ªãå«
ãŸãªããããã¯éªšç±æ¥ãªã®ã§åã³ã©ãŒã²ã³ã
ãæãã骚ã«ãããŠèŠãããåºæã®ïŒæ¬¡å æ§é
ãšè¯ã䌌ãæ§é ãæã€ã  詳现ãªèª¬æ B1 é©çš æ¬çºæãé©çšããã骚ã®æ¬ é¥ã«ã¯ãéªšæ Œçµ
ç¹ãå®å šåããããã«å å¡«ããå¿ èŠããã骚
çµç¹äžã®ç©ºæãå«ãŸãããæ¬çºæã®æ¹æ³ã®é©
çšæ段ãšããŠé©åœãªéªšæ¬ é¥ä¿®åŸ©ã®å»åŠçåã¯
ç£å»åŠçãªæ¹æ³ã«ã¯ãæŽåœ¢å€ç§ãç æ°ã®éªšçµ
ç¹ã®é€å»äžŠã³ã«éãåããåã¯è£ãŠã€ã«ãã
è£å ããããã æ¯ã®åºå®ãæ¯ã®è£å ãå€å·ã®
修埩çããããæ¬çºæã®ã³ã©ãŒã²ã³è£œå€ã®ç
確ãªé©çšæ¹æ³ã¯ãåœæ¥è ã«ç解ãããéãã
骚ã®æ¬ é¥ã®æ§è³ªäžŠã³ã«éžæããæ²»çæ³ã«ãã€
ãŠå€åãããããããªããäžè¬çã«ã¯ãæ¬çº
æã®çµæç©ã¯ããŒã¹ãç¶åã¯ã²ã«ç¶ãšãªãã
ããŒã¹ããæ¬ é¥éšã«å€ç§çã«å å¡«ããŠæ¬ é¥éš
ã®åœ¢ç¶ã«æ圢ããããšãã§ãããæ¬çºæã®ã³
ã©ãŒã²ã³è£œå€ã¯ããŸããæ··åããŠããåžèãª
æžæ¿æ¶²ãšããã°æ¬ é¥éšã«æ³šå ¥ããããšãã§ã
ããã ãããããã®å Žåãæ²»çãã¹ãæ¬ é¥éš
ã¯å ãæŽæµããŠæ°é®®ãªéªšã®è¡šé¢ãé²åºããã
çããŠãã骚现èãæ¬ é¥éšãšé£éããããã«
ããªããã°ãªããªããæ°é®®ãªéªšã®è¡šé¢ã¯ãæ
ä¹ çãªéªšæ§é ã®åæã«èŠãã骚å现èãåŸã
ããã«å¿ èŠãšãªãã B2 ã³ã©ãŒã²ã³è£œå€ 倩ç¶ã³ã©ãŒã²ã³ã¯å€§éšåãäžéãããæ§é
ããæãããã®ãããæ§é ã¯ã°ãªã·ã³ãïŒçš®
é¡ã®ã¢ããé žïŒéåžžããããªã³åã³ãããã
ã·ãããªã³ïŒã«çµåããããªãã¬ããã·ãŒã±
ã³ã¹ã®ç¹°ãè¿ããå«ã¿ãåŸã€ãŠã°ãªã·ã³ãé
äžã§ïŒåç®ããšã«çŸãããããã«ãå šãŠã®ã³
ã©ãŒã²ã³éã®å端æ«ã«ã¯ãã°ãªã·ã³ã®ããªã
ã¬ããã·ãŒã±ã³ã¹ãå«ãŸããããç¶ã§ãªãé
åãååšããããããã®é åã¯å€§æµã®ã³ã©ãŒ
ã²ã³è£œå€ã«äŒŽãå ç«åæ§ã«é¢é£ãããã®ãšè
ãããããå ç«åæ§ã¯ãããããé åãé€å»
ããŠãã¢ãããããããã³ã©ãŒã²ã³ãšããã
ãšã«ãã€ãŠå€§æ¹æ¶å»ã§ãããããã¯ããªãã
ã·ã³åã¯ããã·ã³çã®èçœè³ªåè§£é µçŽ ã«ãã
æ¶åã«ãã€ãŠéæã§ãããããããèçœè³ªå
è§£é µçŽ ã®ç¹ç°æ§ã®éãã®ããããããããé€
å»ã®å®å šãã«å·®ãçãããåŸã€ãŠæãå®å šã«
é€å»ãåŸãç¹å®ã®èçœè³ªåè§£é µçŽ ã奜ãŸã
ããããããé µçŽ ãšããŠããªãã·ã³ãããã
ããã¯å®è³ªçã«å šãŠã®ããããããéšãé€å»
ããããšãã§ããã éãããç¶ã®ããããããé åã¯æ¶æ©ã圢
æããŠåŸ®ç¹ç¶æ§é ãå®å®åããããã«ãå¿ èŠ
ã§ããããããã®é åã¯ãªãžã³æ®åºã«æ¶æ©å¯
èœãªã¢ã«ãããé¡ãå«ããå¿ èŠãªå Žåã¯ãã¢
ããããããã³ã©ãŒã²ã³ã¯äººå·¥çã«æ¶æ©ããª
ããã°ãªããªãã å šãŠã®ã³ã©ãŒã²ã³ã¯äžè¿°ã®ç¹æ§ãå ±æãã
ããã³ã©ãŒã²ã³ã¯äžéãããã®åã ã®éã«ã
ããã¢ããé žã®æ£ç¢ºãªé åºãçæ°Žåç©å«éã
åã³ãžã¹ã«ãã€ãæ¶æ©ã®ååšã®æç¡ã«åºã¥ã
ãŠçŽ10çš®é¡ã«å¯åé¡ãããŠãããæãæ®éã®
äºåã¯ååã³åã§ãåã¯ç®èãè ±åã³
骚äžã«ååšãç¹ç¶èœçŽ°èãã圢æãããããŸ
ããåã¯äž»ã«ç®èäžã«ååšãããä»ã®åã¯
ç¹æ®ãªèåã¯è»éªšããããã¯çŽ°èè¡šé¢ã«ååš
ãããååã³åã¯ãã®ãããäžã«åæ°ã®
ã¢ããé žãå«ãããäžéãããã®ïŒ£ç«¯æ«ã«è¿
æ¥ããïŒåã®ã·ã¹ãã€ã³ãå«ã¿ããã§å éšç
ã«æ¶æ©ãåŸãããåã¯ãããå«ãŸãªãã åã³ã©ãŒã²ã³ã¯ïŒæ¬ã®Î±2ïŒïŒéãšïŒæ¬
ã®Î±1ïŒïŒéãå«ã¿ããã®åã ããã®äžéã®
é åã«1014ã®ã¢ããé žãå«ãããŸããåã ã®
éäžã«ã¯æ°åã®çæ°Žåç©æåãååšããã
åã³ã©ãŒã²ã³ã¯Î±1ïŒïŒïŒïŒæ¬ã®éïŒããå«
ãŸãããããã¯ãã®äžéãããé åã«1026ã®
æ®åºãå«ããåè¿°ã®ããã«ãåã³ã©ãŒã²ã³
ã®äžéé åã®ã«ã«ããã·ç«¯æ«ã«ããäžå¯Ÿã®è¿
æ¥ã·ã¹ãã€ã³ã«ããå éšæ¶æ©ãå®å®åãã
ãããããã®ã³ã©ãŒã²ã³ãçãéäžéããã
ç¶ã®ç«¯éšïŒããããããïŒãå«ããæ¬çºæã«
çšããåæ§æ埮ç¹ç¶ç¶ã¢ããããããã³ã©ãŒ
ã²ã³ã¯ååã³åã®äž¡æ¹ã®ã¢ãããããã
圢æ ãå«ããã骚ã³ã©ãŒã²ã³ç²æ«ã¯å°ãå
ã®ã¢ãããããã圢æ ããæãã ç®èèµ·æºã³ã©ãŒã²ã³ æ¬çºæã®çµæç©ãšããŠæçšãªã¢ããããã
ãåæ§æ埮ç¹ç¶ç¶ç®èã³ã©ãŒã²ã³è£œå€ã®ä»£è¡š
çãªãã®ãšããŠãéåžžåååã¶ã€ããŒã
ïŒZYDERMïŒã»ã³ã©ãŒã²ã³ç§»æ€ç©ïŒZCIïŒãš
ããŠè²©å£²ãããŠããã粟補åçç®èèµ·æºã¢ã
ãããããã³ã©ãŒã²ã³åæ§æ埮ç¹ç¶ç¶æžæ¿ç©
ãããã ããåã³ä»ã®ç®èèµ·æºç²Ÿè£œã¢ãããããã
åæ§æ埮ç¹ç¶ç¶ã³ã©ãŒã²ã³ã¯åœæ¥è ã«è¯ãç¥
ãããŠãããZCIã¯ããåããç®èçŽäžãžã®
補å€ã®æ³šå ¥ã«ããå¹ãã å·å®³éšã®ä¿®åŸ©ãå§ã
ãšããŠãè»éšçµç¹ã«åºãå©çšãããŠãããã
ãããªããããã®æ§ãªè£œå€ã¯ãOFããå«ã¿
èªå°ç骚修埩ãç®çãšããæ¯æææãšã®é¢é£
䜿çšãé€ããšã骚ã®ä¿®åŸ©ã«ã¯äœ¿çšãããŠããª
ããããããå¿çšäŸã¯ç±³åœç¹èš±åºé¡çªå·
348414ïŒ1982幎ïŒæ12æ¥åºé¡ïŒã«é瀺ãããŠ
ããã ãã®ã³ã©ãŒã²ã³è£œå€ã¯åçã®ç®èããåŸã
ãã®ãªã®ã§ãäž»ãšããŠåã³ã©ãŒã²ã³ãšçŽïŒ
ãïŒïŒ ã®åã³ã©ãŒã²ã³ãå«ããã¢ãããã
ããã³ã©ãŒã²ã³ã¯é©åœãªãéæè¡ã䜿ã€ãŠæº¶
液äžã«æžæ¿ãããŸãŸã®ç¶æ ã§æ» èãããã®ã§
å£åãæ¶æ©ãçããªããããã埮ç¹ç¶ç¶ã«å
æ§æãæ» èæ¡ä»¶äžã§å è£ ããã åçµä¹Ÿç¥ç®èã³ã©ãŒã²ã³ ãã®ã³ã©ãŒã²ã³ãåçµä¹Ÿç¥ããŠåçµä¹Ÿç¥ã³
ã©ãŒã²ã³ã²ã«ïŒLCGïŒãšãããšã移æ€åã¯
å å¡«ããã空æäžã«ãã€ãããšåºå®åããåª
ããæ§é ä¿ææ§ã«ããææã®äœçœ®ããã®ç§»å
ã«æµæããèœåã瀺ããããã«ãLCGãã
ãªãã¯ã¹ã¯ç§»æ€éšåãžã®éªšçµç¹ã®çåãåç
é·ãæ¯æãããšããæãŸããããã€å¿ èŠãªæ§
質ã瀺ããåŸã«ãã詳现ã«èª¬æããæ§ã«ãæ¬
çºæã®LCG補å€ã¯PHãåçµé床ãåã³åçµ
æã®æžæ¿æ¶²ã®æ¿åºŠãå¶åŸ¡ããŠåºç¯ãªç©æ§ãåŸ
ãããšãã§ãããææããç¹æ§ã«ãããã
ããæ¬çºæã®LCG補å€ã®ç¹åŸŽã®äžéšã¯ãå®
質çã«äžçŽç©ãå«ãŸãªãã¢ããããããåæ§
æ埮ç¹ç¶ç¶ã³ã©ãŒã²ã³ããæãããšã«ããã
ãã®è£œå€ã埮现ãéã«ãã€ãŠæ» èåŸãæ» èæ¡
件äžã§åŠçããŠãããã¯ãæ¶æ©ã¯å®è³ªçã«å
åšããªããä»å çã«åçµä¹Ÿç¥åŠçãããšãã
ãç¶ã«ãªããã¯ãã¿åã¯éãåç©ã䜿ãã ã
ã§ç°¡åã«åæããŠå»ççšã®é©åœãªåœ¢ç¶ã«ãã
ããšãã§ããã»ã©ã®çµååã瀺ãããã®ãã
ããæ¿¡ãããšããç¶ã®ææãåŸãããããã¯
ä»»æã®åœ¢ç¶ã«æ圢ããŠæ¬ é¥éšã«æ¿å ¥ããããš
ãã§ããã ä»ã®åœ¢æ ã®å»ççšåçµä¹Ÿç¥ã³ã©ãŒã²ã³ã«ã€
ããŠãé瀺ãããŠãããããããã¯æ¬çºæã®
ã³ã©ãŒã²ã³è£œå€ãšã¯ç°ãªããããã¹ã¿
ïŒBattistaãç±³åœç¹èš±ç¬¬3471598å·ïŒã¯çã®ç®
èãå¡©é žã§åŠçããŠèšæœ€åŸã³ã©ãŒã²ã³ç¹ç¶ã
åé¢ããŠåŸãããäžéçãªåŸ®çµæ¶åœ¢æ ã®ã³ã©
ãŒã²ã³è£œå€ã®åçµä¹Ÿç¥äœãé瀺ããŠãããã
ã®ã³ã©ãŒã²ã³ã¯ç²Ÿè£œããŠãããããã¬ããã
ããé€å»ããŠããªãããã®æ§ã«ããŠè£œé ãã
ææã¯åžæ°Žæ§ã¹ãã³ãžãšããŠé©ããããäžçŽ
ç©ãå«ã¿å ç«åæ§ãæãããããæããã«çŽ
æ¥çãªå»ççšã«ã¯é©ããªããããã«ããã®äž
éç圢æ ã®è£œé ã«çšããé žãã¹ãã³ãžäžã«æ®
åãããã¯ã³ãçïŒKuntz et alãç±³åœç¹èš±
第3368911å·ïŒã¯ãé žãæ®åããªãããã«ã
ãã¹ã¿ã®äœ¿çšããæ¯èŒçäžæ®çºæ§ã®é žã®ä»£ã
ãã«ã«ã«ãã³é žãçšããåžæ°Žæ§ã³ã©ãŒã²ã³ã¹
ãã³ãžã®è£œé æ¹æ³ãé瀺ããããã®è£œå€ã«ã¯
å®è³ªçã«çŽç²ãªã³ã©ãŒã²ã³ç¹ç¶ãçšããããš
ãé瀺ãããŠãããããã¬ããããã¯é€å»ã
ãŠããªããå®®ç°ïŒMiyataãç±³åœç¹èš±ç¬¬
4294241å·ïŒã¯ç®èå 垯çšã®åçµä¹Ÿç¥ã³ã©ãŒ
ã²ã³ã·ãŒããé瀺ããŠããããã®ã·ãŒãã¯åŸ®
ç¹ç¶ç¶ã«åæ§æããã¢ããããããã³ã©ãŒã²
ã³ãã補é ãããããæ¬çºæã®LCGãšã¯ã
ããã人工çã«æ¶æ©ãããŠããç¹ã§ç°ãªãã
ãªãŒã¹ïŒRiesãç±³åœç¹èš±ç¬¬4066083å·ïŒã¯ã
å·ã®æ²»ççšã®åžè²©è£œåãã³ã©ãŒã²ã³ããªãŒã¹
ïŒCollagen fleeceãåæšåïŒã®è£œé æ¹æ³ãé
瀺ããŠãããã©ãã¯ãšãããšã«ã¹ïŒLuckã
Danielsãç±³åœç¹èš±ç¬¬4233360å·ïŒã¯åçµä¹Ÿç¥
補å€ã«ã€ããŠèšèŒããŠããããããã¯æ¬çºæ
ã®ãããªãããã§ã¯ãªãçºæ³¡äœã«ãªãã æ¬çºæã®LCGã¯éåžžã粟補åæ§æ埮ç¹ç¶
ç¶ã¢ããããããã³ã©ãŒã²ã³ãäŸãã°ã¶ã€ã
ãŒã ïŒZydermïŒã³ã©ãŒã²ã³ç§»æ€ç©åã¯ã¶
ã€ããŒã ã³ã©ãŒã²ã³ç§»æ€ç©ïŒå ±ã«çã®ç®è
ãã補é ããåæ§æã³ã©ãŒã²ã³è£œå€ã®åæš
åïŒãã補é ããããä»ã®åæ§æ粟補ç®èã³
ã©ãŒã²ã³åæãäŸãã°ä»ã®åºä¹³åç©ã®ç®èã
çšããããšãã§ãããããããããã®å Žå
ããåºçºææã¯ãå¯æº¶åãã圢æ ããåæ§æ
ããå®è³ªçã«çŽç²ãªã³ã©ãŒã²ã³åŸ®ç¹ç¶ãšãã
å·¥çšã«ãã€ãŠããããã®åæãã補é ããªã
ãã°ãªããªããããã«ãããããããã¯é©åœ
ãªå·¥çšãäŸãã°ããªãã·ã³æ¶åçã«ãã€ãŠé€
å»ããªããã°ãªããªããå žåçã«ã¯ãããã
粟補補å€ã¯åºçºææã埮现ã«åå²åŸãé žçŽ å
ã³ïŒåã¯é©åœãªPHæ¡ä»¶äžã§éã³ã©ãŒã²ã³ç©è³ª
ãç Žå£åã¯æœåºããç¶ããŠã³ã©ãŒã²ã³ãããª
ãã·ã³çã®æ¶åæ§é µçŽ ã§åŠçããŠããããã
ããé€å»ãã埮现ãéããŠæ» èããPHåã³å¡©
æ¿åºŠãé©åœã«èª¿ç¯ããŠïŒã€ãŸããé žæ§ããäž
æ§ã§ïŒã³ã©ãŒã²ã³åŸ®ç¹ç¶ãåæ§æããŠè£œé ã
ãããã®æ§ãªè£œå€ã¯åœæ¥è ã«ç¥ãããŠããã
äºå®ããããçšãã補åãåžè²©ãããŠããã åçµä¹Ÿç¥åœ¢æ ã®è£œé ãžã®åæ§æã³ã©ãŒã²ã³
ã®äœ¿çšã¯ãæ» èéçšã§ã®å£åé²æ¢ã®èŠ³ç¹ãã
ãéèŠã§ãããã³ã©ãŒã²ã³ã¯è£œé éçšã®äžæ®µ
éã§å¯æº¶å圢ããšããã埮现ãéãå¯èœã§ã
ãã®å·¥çšã¯å®å šã«äžæ§ã®å·¥çšãªã®ã§æ§é ã«é¡
èãªååŠçãç©ççãªå€åãçããªãã以åŸ
ã®å·¥çšãæ» èç¶æ ã§å®æœããã°ããã以äžã¯
æ» èãå¿ èŠãšããªãã®ã§ãçæç©ã«å ç±åã¯
γç·ç §å°çã®ããéé ·ãªæ» èæ¡ä»¶ãçšããå Ž
åã«çããæ§ãªå£åãæ¶æ©ãçããªãã æ¬çºæã®LCGã®è£œé ã«ãããŠã¯ãé©åœãª
ã³ã©ãŒã²ã³ã®æžæ¿æ¶²ãæ¿åºŠçŽ20ã100mgïŒml
ãšããŠæ³šåããããã·ãŒãç¶ã«æŒåºæ圢ã
ãããããã®æ圢äœãç¶ããŠçŽâ10ãâ50â
ã§åçµåŸã³ã³ãã³ãµãŒæž©åºŠçŽâ45ãâ55âã
ã·ãšã«ã枩床çŽâ30âãšããŠçŽ10ã
100millitorrã§åçµä¹Ÿç¥ãããïŒãïŒæ¥éå
çµä¹Ÿç¥åŸã·ãšã«ã枩床ã15ã25âã«äžæãã
ããã«24æéåŸã«åçµä¹Ÿç¥åšããLCGãå
ãåºãã å¥æ³ãšããŠãå¯æº¶å圢ã®ç²Ÿè£œã³ã©ãŒã²ã³ã
çšããããšãã§ããããã®æ§ãªæº¶æ¶²ã¯ç²Ÿè£œã¢
ããããããã³ã©ãŒã²ã³ãçŽPHïŒãïŒã§æ°Žæº¶
液äžã«æº¶è§£ããéæ埮现ãéã§æ» èåŸãäŸã
ã°ãªã³é žå¡©ç·©è¡æ¶²ãçšããŠPHãã»ãŒäžæ§ãšã
åæ§æ圢æ ãæ²æŸ±ãããŠè£œé ãããçæãã
æ²æŸ±ã³ã©ãŒã²ã³ãé å¿åé¢æ³ã§æ¡éãããã¬
ããåããã³ã©ãŒã²ã³ãäžæ§ã®ç·©è¡æ¶²äžã«å
æžæ¿ãããŠåè¿°ã®ããã«åŠçããã ç¹å®ã®çšéã«ãããŠããåªããçµæãåŸã
ãããåè¿°ã®æ¹æ³ã®æ¹è¯æ¹æ³ã«çžåœããå¥ã®
åçµä¹Ÿç¥æ¹æ³ããããã³ã©ãŒã²ã³æžæ¿æ¶²ãæ»
èããå¹é€æ¿ïŒäŸãã°ã35mmïŒäžã«æ³šåãã
åŸããã泚åäœãã¹ãããŠã©çã§å¹³æ»ã«ã
ãã次ãã§ãã®æ³šåäœãåçµãçŽâ100ãâ
50âã奜ãŸããã¯çŽâ80âã«ïŒæéä¿æåŸå
çµä¹Ÿç¥ãããçŽ10ã100millitorrçŽ24æéå
çµä¹Ÿç¥ããŠä¹Ÿç¥ãããåãæ°mmã®å€å質ã®ã
ãããåŸãã 骚起æºã³ã©ãŒã²ã³ æ¬çºæã§çšãã骚ã³ã©ãŒã²ã³ç²æ«ïŒBCPïŒ
ã¯ç¡æ©æåãé€å»ãã骚ããåŸããã®ã§ãåŸ
ã€ãŠãã®ã³ã©ãŒã²ã³æåã¯å°ãåã³ã©ãŒã²
ã³ã§ããããã®ã³ã©ãŒã²ã³è£œå€ã¯åŸæ¥æ§é ã
ãã圢æ ã®ã³ã©ãŒã²ã³ãšã¯ç©ççãååŠçç¹
æ§ãç°ãªãæ°ç©è³ªã§ããã也ç¥ç²æ«ç¶ã§äŸ¿å©
ã«è²¯èµããããšãã§ãããéåžžãçãè±çã®
åºä¹³åç©ã®éªšã奜ãŸããã¯ç·»å¯ãªéªšãæŽæµã
åçµãç²ç åŸãåžžæ³ãçšããŠã¯å¡©é žçã®é©åœ
ãªé žã§ç¡æ©ç©ãé€å»ãããæ®åææ©ç©ãåé¢
ããèçœè³ªåè§£é µçŽ ãé次çã«ãããã¯çµã¿
åãããŠäœ¿çšããŠæ¶åããããªãªããŒãšã°ã©
ã³ãïŒOliverãGrantãè±åœç¹èš±ã
GB1565340AïŒãèšèŒããæ§ã«ãéã³ã©ãŒã²
ã³è³ªã®èçœãéžæçã«å£åãããããªãã·ã³
çã®äžæ§èçœè³ªåè§£é µçŽ ã奜ãŸãããããã·
ã³çã®ç¹å®ã®é žæ§èçœè³ªåè§£é µçŽ ã¯ã³ã©ãŒã²
ã³ãéšåçã«æ¶åããã®ã§å¥œãŸãããªããé
èçœæ§ã®éªšæåãã³ã³ããã€ãããŒãŒããã¢
ã«ããããŒãŒãåã³çš®ã ã®ãã¯ã¬ã¢ãŒãŒçã®
é©åœãªé µçŽ ãçšããŠé€å»ã§ããããã¡ããã³
ã©ã²ããŒãŒã®äœ¿çšã¯äžé©åœã§ãããé©åœãªé µ
çŽ ã䜿çšããŠåŠçããåŸã®äžæº¶æ§ç©è³ªã¯
BCP圢ã®ç²Ÿè£œã¢ããããããããæããã
ãã¯Î³ç·ç §å°åã¯å ç±çã®æ¢ç¥ã®æ¹æ³ã§æ» è
åŸäœ¿çšããããšãã§ãããããªãã·ã³åŠçåŸ
ã«æ®åããå šãŠã®ããããããã®æ®åæåæ§
å¹æãç·©åãããã®ã§ããã®åã®ã³ã©ãŒã²ã³
ã§ã®æ¶æ©ã®ååšã¯å¥œãŸããå Žåãå€ãã ãã®æ§ã«ããŠåŸãBCPã¯æ°èŠãªãã®ã§ã
ããããã¯æ¬è³ªçã«åã³ã©ãŒã²ã³ããæ
ããèŠæãäžã骚ã³ã©ãŒã²ã³ã®å ã®ååæ§é
ãä¿æããŠããããããããããã¯å«ãŸãª
ãã ãã®BCPã¯ãé©åœã«ååŠçãã骚ã®æ¬ é¥
äžã«å§å ¥ããŠäœ¿çšããããã«çççç·©è¡æ¶²äž
ã«åæžæ¿ããã æ··åç© æ··åç©ã䜿ã€ãŠæ¬çºæã®ç§»æ€çåã¯ããŒã¹
ãç¶ä¿®åŸ©ææã補é ããå Žåã¯ãææã®åã
æ±ãäžã®å¿ èŠæ§åã³ä¿®åŸ©éšäœã«ãããããšã
äºæ³ãããå¿åã«å¯ŸåŠããã®ã«å¿ èŠãªç©æ§ã«
å¿ããæ¯çç¯å²ã®ãZCIçã®åæ§æ埮ç¹ç¶ç¶
ã¢ããããããã³ã©ãŒã²ã³ã®æžæ¿æ¶²åã³
BCPã䜿ã€ãŠè£œé ãããBCPéãå¢ããšçµ
æç©ã«èééæ§åã³èå¿åæ§ãä»äžããããš
ãã§ããã®ã«å¯ŸããŠãZCIã«å¯ŸããBCPæ¯ç
ãæžãããšæè»æ§ãå¢ãé©çšæ§ãè¯ããªãã
åŸã€ãŠæ¬çºæã®æ¹æ³ã¯ãåŸæ¥æ¹æ³ã«æ¯èŒããŠ
çäœã®æ¬ é¥ã修埩ããéããã®æ§è³ªã«å¿ããŠ
極ããŠé å¿æ§ã«å¯ãã æ¯çã®ç¯å²ã¯ãã¡ããããããã®æåãå
ç¬ã§äœ¿çšã§ããã»ã©å€§ããã奜é©ãªæ··åç©ã¯
æ¬ é¥ã®æ§è³ªã«ããã®ã§ãäžè¬çã«å¥œãŸããå
äžã®ç¯å²ã¯ç¹å®ã§ããªããã ããäžè¬çã«
ã¯ãééããããæ¬ é¥éšã«å¯ŸããŠã¯çŽ50ïŒ
ZCIïŒ50ïŒ BCPãçŽ10ïŒ ZCIïŒ90ïŒ BCPïŒé
éïŒ ïŒã®ç¯å²ã奜ãŸãããæ¯æ ¹èåã¯è¡šé¢éš
ã®æ¬ é¥ã«å¯ŸããŠã¯çŽ90ïŒ ZCIïŒ10ïŒ BCPãçŽ
50ïŒ ZCIïŒ50ïŒ BCPïŒééïŒ ïŒã奜ãŸããã
ïŒäžèšã®æ¯çã¯ZCIã®35mgïŒmlæžæ¿æ¶²ãæ³å®
ãããã®ã§ãééã¯å šæžæ¿æ¶²ã®ééãèšãïŒã  å®æœäŸ 以äžã«æ¬çºæã説æããããããã¯æ¬çºæãé
å®ããããšãããã®ã§ã¯ãªãã C.1 ZCIè£œå€ ã¶ã€ããŒã ã»ã³ã©ãŒã²ã³ç§»æ€ç©ïŒCollagen
Corporationãã«ãªããªã«ãã¢å·ãããã¢ã«ã
ããè³Œå ¥ïŒãåæ§æ埮ç¹ç¶ç¶ã¢ããããããæ
åãšããŠäœ¿çšãããåæ§æ倩ç¶åã³ã©ãŒã²ã³åŸ®
ç¹ç¶ãæ¿åºŠçŽ35mgïŒmlã§çšããããã®è£œå€ã¯å
å·¥æã«ãéããŠæ» èããã®ã§ãå ç±åã¯ç §å°ç
ã®å£åã被ããå·¥çšã¯åããŠããªãã C.2 ICGè£œå€ ïŒ¡ 埮现ãéã§æ» èããçŽPHïŒãïŒã®ããã·ã³
å¯æº¶åçç®ã³ã©ãŒã²ã³æ°Žæº¶æ¶²ããªã³é žå¡©ç·©è¡æ¶²
ã§PH7.4ã«èª¿ç¯ãããæ²æŸ±ããã³ã©ãŒã²ã³ãé
å¿åé¢ããŠæéåŸãPH7.4ã®ãªã³é žå¡©ç·©è¡æ¶²äž
ã«æ¿åºŠ35mgïŒmlã§æžæ¿ããããæžæ¿æ¶²ãã·ãŒã
ç¶ã«æ³šåãããã®ã·ãŒããâ25âã§åçµåŸã³ã³
ãã³ãµãŒæž©åºŠâ50âã25millitorrã§åçµä¹Ÿç¥ã
ããåçµä¹Ÿç¥ããã·ãŒããâ30âã§ïŒæ¥é貯èµ
åŸã枩床ãåã³20âã«äžã䜿çšçŽåã®24æéä¿
æããã  å¥æ³ïŒæãã¯æ¹è¯æ³ïŒãšããŠãçŽïŒc.c.ã®ã¶
ã€ããŒã ã»ã³ã©ãŒã²ã³ç§»æ€ç©ïŒã€ã³ãã©ã³ãïŒ
ãæ» èãã35mmçµç¹å¹é€æ¿äžã«æ³šåããã¹ãã
ãŠã©ã§å¹³æ»åããããã®ã³ã©ãŒã²ã³ã²ã«ãåçµ
ããâ80âã«çŽïŒæéä¿æãããç¶ããŠã³ã©ãŒ
ã²ã³ã²ã«ã也ç¥ãããŸã§çŽ24æéåçµä¹Ÿç¥ãã
çŽåŸ35mmãå§ãïŒãïŒmmã®å€å質çœè²ãã€ã¹ã¯
ãåŸãã C.3 BCP補å€ïŒçïŒ çã®å€§è ¿éªšãææŽãããŠä»çããè»éšçµç¹ã
é€ãã骚ã®é¢ç¯ç«¯ã骚端æ¿è¿ãã§é€å»ããŠæ¬è³ª
çã«ç·»å¯ãªéªšãåŸãã骚幹ã液äœçªçŽ ïŒLN2ïŒ
ã§å·åŽãã軞æ¹åã«å²ã€ãŠéªšé«ãåãé€ããã
ç·»å¯ãªéªšçãLN2枩床ã§ãžãšãŒã¯ã©ãã·ã€ãŒã
䜿ã€ãŠç²åŸïŒmm以äžã®ç Žçã«ç Žç ããããã®éªš
çããã³ããŒãã«ã䜿ãããã¯ãLN2枩床ã§ç²
ç ããã 骚ç²ãæµæ°Žäžã§ãµãã€ãŠã125ã250ÎŒïœãš
250ã450ÎŒïœã®ïŒã€ã®ç²åŸéšåã«åããããã®
ïŒçš®é¡ã®ç²åŸéšåãå¹³è¡ããŠãåå¥ã«å å·¥ã
ãã 0.5M HClãçšãïŒéªšç²ïŒïœã«å¯ŸããŠHCl溶
液25mlïŒïŒã1.5æéåŸã«æ°ããé žãšäº€æããŠã
宀枩äžïŒæéãããŠéªšç²ããç¡æ©æåãé€å»ã
ããç¡æ©æåé€å»å·¥çšã®çµãã«ã骚ç²ãïŒåæ°Ž
æŽãé žæº¶æ§ç¡æ©ç©ãé€å»ãããç¡æ©ç©ãé€å»ã
ã骚ç²ããèçœè³ªå解åŠçã«å ç«ã€ãŠåçµä¹Ÿç¥
ããã åçµä¹Ÿç¥ãã骚ç²ãããªãã·ã³ã§æ¶åãã
ïŒ0.5mgïŒml NaN3ãå«ã0.1M Na2HPO4 ïŒ
mlåœã骚ç²50mgåã³ããªãã·ã³ïŒmgïŒããªãã¡
ããªãã·ã³ïŒéªšç²ïŒïŒïŒ25ïŒãé µçŽ ã«ããæ¶å
ã15âã§10æ¥éè¡ã€ããæ¶åäžæŸæ¶²ãããŠã¬ã
ãæ³ã§å 溶æ§èçœè³ªã«ã€ããŠåæããæ¶åã®é²
è¡ãç£èŠããã ããªãã·ã³æ¶åçæç©ãé€ãããã骚ç²ãæ²
éãããŠããäžæŸã¿æ¶²ãåé¢ããåºäœåã«4M
NaCl溶液ïŒ10ïŒïŒïŒå®¹ç©ïŒééïŒãå ããã
骚ç²ã宀枩ã§ïŒæéæ¹æãããã®æç¹ã§ç²æ«ã
æ²éãããŠãã«ã³ããŒã·ãšã³ããã4M NaCl
ã«ããæœåºãåèšïŒåç¹°ãè¿ããã å¡©åãããªãŠã ãé€ãããã10åéã®ç±³åœè¬
å±æ¹æ³šå°çšæ°ŽïŒWFIïŒäžã§NaClæœåºã«ã€ããŠ
ã®èšèŒãšåæ§ã«ããŠ10åéæ¹æããŠïŒåæŽæµã
ãã 次ãã§éªšç²ã10åéã®ã¢ã»ãã³ã§ïŒåæœåºã
ååšããå šãŠã®è質ãé€å»ãããã¢ã»ãã³æœåº
åŸã骚ç²ãWFIã§ïŒåæŽæµããç空ãéããŠ
ããåçµä¹Ÿç¥ããŠéªšã³ã©ãŒã²ã³ç²æ«ïŒBCPïŒ
ãåŸãã BCPè©Šæãè質ãã°ãªã³ã¹ã¢ããã°ãªã«ã³
ïŒglycosaminoâglycanïŒãåã³ã¢ããé žçµæç©
ã«ã€ããŠååŠçã«ãæ®åããªãã·ã³ãçèµ€è¡ç
现èãåã³çã³ã©ãŒã²ã³ããããããïŒã³ã©ãŒ
ã²ã³ã®æåæ§ç«¯æ«ïŒã«ã€ããŠå ç«åŠçã«ããã
ã«è¶ 埮现æ§é ã«ã€ããŠé»åé¡åŸ®é¡çã«åæã
ããããªãã·ã³åŠçãé²ãã«ã€ããŠã奜ãŸãã
ã¯ïŒã10æ¥ã§ãBCPã¯æ¬¡ç¬¬ã«ããããããã
ã»ãšãã©å«ãŸãªãçŽç²ã®åçã³ã©ãŒã²ã³ã«ãª
ã€ããé»åé¡åŸ®é¡ã«ãããç¹åŸŽçãªåž¯ç¶ããªã
ã³ã©ãŒã²ã³åŸ®ç¹ç¶ãšç骚ã®çµç¹ãèªããããã
ãŸããã¢ããé žçµæãããååŠçã«çŽç²ãªã³ã©
ãŒã²ã³ã§ããããšãå€ã€ãã ãã®æ§ã«ããŠè£œé ããBCPã«ã¯ïŒçš®é¡ã«ã®
ç²åŸããããããã«ç¬¬ïŒè¡šã«ç€ºãããã«ããªã
ã·ã³åŠç床åã®ç°ãªããã®ããã€ããå šãŠã®è©Š
æã¯1.5Mradã§Î³ç·ç §å°ããŠæ» èããã ãè¡šã C.4 BCPãZCIæ··åè£œå€ åé ã§2Cåã³3Cãšåœåãã骚ã³ã©ãŒã²ã³ç²
æ«ïŒBCPïŒã55ïŒ45ïŒééæ¯ïŒã§æ··åãã
1.5Mradã§Î³ç·ç §å°ããŠæ» èããã ãã®æ» èBCPæ··åç©ã䜿ã€ãŠïŒãããã®
BCPïŒZCIæ··åç©ã補é ãããããªãã¡ã也ç¥
BCP0.33ïœãZCIïŒ35mgïŒmlã®æžæ¿æ¶²ãã€ãŸã
åºäœåçŽ0.67ïœïŒ0.035ïœïŒmlãšããŠïŒ0.67ïœãš
æ··åãZCIã®33ïŒ BCPæ··åç©ã調補ããããŸ
ããBCP0.17ïœãZCIïŒ35mgïŒmlæžæ¿æ¶²ïŒ0.83ïœ
ãšæ··åããŠç¬¬ïŒã®æ··åç©ã調補ããããããã®
ææãããããååã«æ··åããŠïŒã1/4c.c.ã®æ³š
å°åšã«æºããã以äžã®æé ã«çšããã C.5 ZCIã«ãã骚ã®æ¬ é¥ã®ä¿®åŸ© çåŸïŒãïŒé±éã®45å¹ã®ã©ããã«éº»é ãã
ããé ç®ãå転ããŠé è骚èãé€å»ãããæ¯ç§
çšããªã«ã䜿ã€ãŠé èåŽå£éªšã«ïŒÃïŒmmã®è²«é
æ¬ é¥ãå·Šå³å¯Ÿç§°ã«èšãããC.1ã«èšèŒããæ³šå ¥
å¯èœãªã³ã©ãŒã²ã³ã²ã«ãå°åã¹ãããŠã©ã䜿ã€
ãŠæ¬ é¥äžã«å å¡«ããé ç®ãå ã«æ»ããŠçž«åã
ããæ¬ é¥å ã®çåé床ã移æ€åŸïŒãïŒãïŒåã³
16é±éåŸã«ïŒžç·äžŠã³ã«çµç¹åŠçã«ç£èŠããã ïŒé±éåŸã«ã¯ã³ã©ãŒã²ã³ã²ã«å ã«çµç¹åŠçã«
æ°ãã骚现èïŒéªšèœçŽ°èïŒã®å³¶ãšåºè³ªãèªãã
ãããïŒé±éåŸãŸã§ã«ã¯å€§åã®äºäŸã§æ°ãã骚
ãæ¬ é¥å šäœã«åºãããæ¬ é¥ã®åæ端éšéã®èå
ç©åã³ãã®æ°ãã骚ãçãå§ãããïŒã16é±é
ã®éã«ãæ°æ§ã®éªšã®çµåéšãã»ãšãã©èŠåãã
ããªããªã€ãããŸããæ°ãã骚ã¯åæ§æãã
ãŠãæ¬ é¥éšã«å ããååšãã骚ã«å žåçãªæç
ãªéªšé«è ãæããç·»å¯ãªéªšã®å±€ãšãªã€ããã©ã
ãããé€ãå»ã€ãé èã®ïŒžç·ããã16é±éåŸã®
æ¬ é¥äžã«å€éã®ïŒžç·äžééæ§ã®éªšã®ååšã確èª
ãããã移æ€ããŠããªãå·Šå³å¯Ÿç§°ã®é èåŽå£éªš
æ¬ é¥ãæããã©ããã§ã¯èŠ³å¯æé16é±éã§ã¯é¡
èãªçåã¯èªããããªãã€ããåŸè ã®å Žåã骚
圢æ掻åã¯æ¬ é¥ã®åæ端ã®å°éšåã«éå®ããã
æ¬ é¥ã®æ®éšã¯ãããçµåçµç¹ã§æºããããŠã
ãã ãã®æ§ã«ãåæ§æã³ã©ãŒã²ã³ç¹ç¶ã«ãã€ãŠã
äŒå°éªšçé·ã®æ¯æåºè³ªãæäŸããããã®æ°èŠã§
æçšãªæ¹æ³ãåŸãããã C.6 LCGãçšããé èæ¬ é¥ã®ä¿®åŸ© çåŸçŽïŒé±éã®ã©ããã«éº»é ãæœããé ç®ã
å転ããŠé è骚èãé€å»ãããæ¯ç§çšããªã«ã
䜿ã€ãŠé èåŽå£ã®éªšã«ïŒÃïŒmmã®è²«éæ¬ é¥ãå·Š
å³å¯Ÿç§°ã«èšãããC.2Bã«æºããŠè£œé ããåçµ
也ç¥ã³ã©ãŒã²ã³ãæ¬ é¥ããè¥å¹²å€§ããã®çŽ°çç¶
ã«åæãã移æ€çãæ¬ é¥éšã«ãã€ããå°å ¥ãã
ãããã«ãããäžéšã®çŽ°çã¯æ¬ é¥äžã«ä¹Ÿç¥ç¶æ
ã§å ¥ããã®äžã§æ°Žåãããããäžéšã¯ç§»æ€ã«å
ç«ã€ãŠæ°Žåãããã移æ€åŸãé ç®ãå ã«æ»ããŠ
çž«åãããæ¬ é¥å éšã®çåé床ãã移æ€ïŒåã³
ïŒé±éåŸã«çµç¹åŠçã«è©äŸ¡ããã ïŒé±éåŸã«ã¯ç§»æ€çäžã«çµåçµç¹åã³è¡ç®¡ã
åå浞最ããããæ°ãã骚ã®åœ¢æã¯æ¥µããŠéå®
ãããŠãããåé ã«èšèŒããåã®é移æ€æ¬ é¥ã¯
çåããè»éšçµç¹ã§æºãããããŸãŸã ã€ããã
修埩ããæ¬ é¥ã§ã¯28æ¥åŸãŸã§ã«ã¯ç§»æ€çå šäœã«
æ°ãã骚ã®åœ¢æãèªããããããŸããæ¬ é¥ã®å
æ端éšãšç§»æ€çã®çé¢ã«æ©ããæ¢åã®éªšãšã®è
åã®åŸŽåãèªããããã56æ¥åŸãŸã§ã«ã¯ãæç
ãªéªšé«è ãæããæçãã骚ã®ååšãæ¬ é¥å šäœ
ã«èªããããã LCGã¯å®¹æã«åæããŠãäŒå°éªšçé·ãæ¯æ
å¯èœãªæ¿å ¥ç©ãæ圢ããããšãã§ãããåŸãã
ãåçµä¹Ÿç¥åæ§æã³ã©ãŒã²ã³ç¹ç¶ã®ãããã¯ã
ã®ç®çã«å¥œé©ãªææã§ããã C.7 骚ã®ä¿®åŸ©ãžã®BCPã®äœ¿çš çåŸïŒé±éã®ã©ããã«éº»é ãæœããé èã®å·Š
å³ã®å£éªšã«ïŒÃïŒmmã®æ¬ é¥ãèšãããæ¯ç§çšã
ãªã«ã§é èã«è²«éåãéããåè¿°ã®æ§ã«ããŠèª¿
補ããBCPãæ» èé£å¡©æ°Žã§æ¹¿æœ€åŸæ¬ é¥ã«å å¡«
ãããå¯Ÿç §çšæ¬ é¥ã¯æªå å¡«ã®ãŸãŸæ®ãããåèš
第ïŒè¡šã®BCPè©Šæ2Bã3Zã3Aã3Bãåã³3C
ãè©Šéšããã移æ€åŸïŒåã³ïŒé±éåŸã«è©Šæãæ¡
åããçµç¹åŠçã«æ€æ»ããã è©Šæ3ZïŒããªãã·ã³æ¶åå®æœããïŒåã³3A
ïŒããªãã·ã³æ¶åïŒæ¥ïŒã¯æåæ§æåã®èšŒæ ã
䌎ãççã瀺ãããè©Šæ2Bã3Bãåã³3Cã¯ïŒ
é±éã§å€æ žæ§çŽ°èåå¿ã骚èœçŽ°èåå¿ã䌎ã
BCPã®æ¶åã䞊ã³ã«æ°ããç·»å¯ãªéªšã®æ²çã
瀺ãããïŒé±éã®æç¹ã§ã移æ€çå šäœã«å€éã®
骚ã圢æãããæ°æ§éªšã®èåã®åŸŽåãèªããã
ããå¯Ÿç §æ¬ é¥ã«ã¯åæ端éšã§å ããªéªšã®çé·ã
èªããããã«éããªãã€ãã BCPè©Šæ3Zã移æ€ããã©ããã®è¡æž äžã«ã¯
BCPã«å¯Ÿãã埪ç°æäœãååšãããè©Šéšãã
ä»ã®BCPè©Šæã¯æäœåå¿ãèªçºããªãã€ãã ãããã®çµæã第ïŒè¡šã«èŠçŽããŠç€ºãã ãè¡šã C.8 BCPã®å ç«åæ§åå¿ã«ã€ããŠã®è ¹èæœ æµå
æ BCPè©Šæ2Zã2Aã2Bãåã³3Bã30mgããª
ã³é žå¡©ã§ç·©è¡ããé£å¡©æ°ŽïŒPBSïŒïŒmlã«æžæ¿
ãããã©ããã®è ¹è å ã«æ³šå ¥ãããïŒãïŒã
14ãåã³28æ¥åŸã«è ¹è ãPBS100mlã§æœ æµããŠ
现èãéžå¥èšæ°åã³å šæ°èšæ°ããççã®å®éç
尺床ãšããããŸããBCP移æ€çãçµç¹åŠçã«
æ€æ»ããè¡æž ã埪ç°æäœã®å°ºåºŠãšããã å šè©Šæã§ïŒæ¥åŸã«é·ç§»çãªå¥œäžçåå¿ãèªã
ããããã®ææã«ç¹ç°çãªæ§è³ªã«é¢é£ãããã®
ãšèãããããïŒã14ãåã³28æ¥ã®æç¹ã§ã¯å¿
ç现èã¯ãã€ã¯ããã¢ãŒãžãæ¯é çã«ãªãã移
æ€çã®çµç¹åŠçæ€æ»ã«ããã°28æ¥åŸã«ãããŠæ
ããã«å€éã®BCPã®æ¶åãèªããããã極ã
埮éã®å ç«æ§çŽ°èïŒãªã³ãçïŒãåžžæååšã
ããè¡æž åŠæ€æ»ã®çµæã2Zã移æ€ããã©ãã
ã§BCPã«å¯Ÿããæäœã®æ»Žå®éãããªãã®éã«
éããããšãå€ã€ãã2Aã2Bã2Cãåã¯3B
ã移æ€ããã©ããã§ã¯æäœåå¿ãçºçŸããªãã€
ãã BCPã¯äŒå°æ©æ§ã§ã®éªšã®ä¿®åŸ©ã«æçšãªã骚
ãåæãšããæ°èŠãªåºæã§ããã骚ã³ã©ãŒã²ã³
ç²æ«ïŒBCPïŒã¯éªšã®æ¬ é¥éšã®åœ¢ç¶ã«ããããš
ãã§ããæéžãã骚ã®èå¿åæ§ã®è£å¡«ç©ã§ãæ°
ãã骚ã®çé·ãæ¯æããã C.9 骚ã®ä¿®åŸ©ãžã®BCPïŒZCIæ··åç©ã®äœ¿çš çåŸïŒãïŒé±éã®ã©ãã24å¹ã«éº»é ãæœãã
é èã®å·Šå³ã®åŽéªšã«ïŒÃïŒmmã®æ¬ é¥ãèšããã
æ¯ç§çšããªã«ã䜿ã€ãŠé èã«è²«éåãèšããå
èšã®æ§ã«ããŠè£œé ããïŒçš®é¡ã®BCPïŒZCIæ··å
ç©ãåäžã«å å¡«ãããå¯Ÿç §æ¬ é¥ã«ã¯BCPåã¯
ZCIåäœãå å¡«ãããæªå å¡«ãšããã移æ€åŸïŒ
åã³ïŒé±éåŸã«è©Šæãæ¡åãçµç¹åŠçã«æ€æ»ã
ãã BCPïŒZCIæ··åç©ãå å¡«ããæ¬ é¥ã§ã¯ç§»æ€åŸ
ïŒé±éã§æ®éãããæ©ã骚ã®çé·ãçãããã
ããBCPïŒZCIæ··åç©ã¯å¿ ãããåäžã§ãªãã
ããæ¬ é¥ã®ç¹å®éšäœã«ååšããã³ã©ãŒã²ã³è³ªç§»
æ€çäžã®æ¯é çš®ïŒã€ãŸããBCPåã¯ZCIïŒã«ã
ã€ãŠéªšã®åœ¢æãã¿ãŒã³ãå€åããã ïŒé±éç®ãŸã§ã«ã¯BCPïŒZCIæ··åç©ã®ZCIæ
åäžã§æ°ãã骚ãå€éã«åœ¢æãããBCPç²å
ã¯æ°ãã骚圢æ§æŽ»æ§ã®äžå¿éšã«åã蟌ãŸãã€ã€
ãã€ãããããæ©æã®åæ§æãšçžä¿ã€ãŠãæ¬ é¥
éšã«åºããæ°ãã骚ã®å€èŠ³ã14æ¥ã®æç¹ããã
åäžæ§ã垯ã³ãŠããã移æ€ããå¯Ÿç §æ¬ é¥ïŒã€ãŸ
ããBCPåç¬åã³ZCIåç¬ïŒã«ã¯äžè¿°ã®ç 究ã§
芳å¯ãããç¹åŸŽçãªåœ¢åŒã®éªšçºç掻æ§ãèªãã
ããã移æ€ããªãã€ãå¯Ÿç §æ¬ é¥ã§ã¯æ¬ é¥ã®åæ
端éšã«å ããªéªšã®çé·ãèªããããã«éããªã
ã€ãã 匟æ§ã®ã²ã«ç¶æžæ¿ç©ã圢æãã粟補ã¢ããã
ãããåæ§æ埮ç¹ç¶ç¶ã³ã©ãŒã²ã³ãšå§çž®åŒ·åºŠã
ä»äžãã骚ã³ã©ãŒã²ã³ç²æ«ãšã®çžå¯Ÿéãå€ãã
ããšã«ãã€ãŠãäŒå°ã«ãã骚ã®ä¿®åŸ©ã«é©ããåº
質ãåŸãäžã§ãå€æ§æ§ã«å¯ãæçšãªç§»æ€ææã
補é ã§ããã
ã®ä¿®åŸ©ã«é¢ãããããã«è©³ããã¯ãæ¬çºæã¯ã³ã©
ãŒã²ã³ãåºç€ãšãã移æ€ææãçšããŠéªšã®äŒå°ã«
ããè£ä¿®ãä¿ã骚ã®ä¿®åŸ©æ¹æ³ã«é¢ããããã®ã³ã©
ãŒã²ã³ææã¯é«åºŠã«ç²Ÿè£œãããéå ç«æ§ã®ãã®ã§
ãããæãŸããå Žåã¯ã被移æ€äœãšç°ãªãçš®ã«å±
ãããã®ã§ãè¯ãããã®ã³ã©ãŒã²ã³ã¯ãç®èåã¯
骚ç±æ¥ã®ææåã¯ãããã®æ··åç©ããã®åæ§ææ
æã§ããã æè¡çèæ¯ïŒœ æ¬ é¥ã®ãã骚ã®ä¿®åŸ©ã¯äœäžçŽã«ãäºã€ãŠäººé¡ã
æ©ãŸããŠããåé¡ã§ãããæ¯èŒçæè¿ãŸã§ã¯æã
ã骚ãåºå®ã骚çµç¹ãæå·éšã«èªç¶ã«åçé·ãã
ã®ã«é Œãã®ãå¯äžã®å®çšçãªæ¹æ³ã ã€ããã ãã
ãããå€ç§æè¡ã®é²æ©ã«ãã€ãŠã移æ€ãã骚代çš
ç©ãæå·ãåãã骚ãç æ°ã®éªšæ§é äœã®è£å¡«ã®ã¿
ãªãããéªšæ Œæ§é äžã®å 倩çåã³åŸå€©çãªæ¬ é¥ã®
修埩ã«ããå©çšã§ããããã«ãªã€ãã ãã以æ¥ãåºç¯ãªææãå©çšãããéªšå šäœãäŸ
ãã°è¡é¢ç¯éšïŒç±³åœç¹èš±ç¬¬3820167å·ïŒãæ¯ïŒç±³
åœç¹èš±ç¬¬4186486å·ïŒã眮æããããã®ç²ŸåŠãªæ¹
æ³ãé瀺ãããŠããã䜿çšãããææã®äžã«ã¯ã
ãã¿ããŠã ïŒEPå ¬é0071242ã1983幎ïŒæïŒæ¥ïŒ
ç±³åœç¹èš±ç¬¬3918100å·ïŒçã®éå±é¡ãé žåã¢ã«ã
ããŠã ïŒç±³åœç¹èš±ç¬¬3919723å·ïŒçã®ã»ã©ããã¯
é¡ãæ圢ãããã¯åŠçãã骚ïŒç±³åœç¹èš±ç¬¬
3318774ïŒãåã³äŸãã°å¯ææ§ã®ãããç¶ã«å§çž®ã
ã骚ç²ïŒç±³åœç¹èš±ç¬¬2621145å·ïŒçã®çš®ã ã®éªšè£œ
å€ãããã éªšæ Œçµç¹ãç¡æ©æåãšææ©æåãå«ãããšã¯å€
ãããç¥ãããŠãããæããã¯éªšæ§é ã®åŒ·åºŠãšç¡¬
ããæ ã€ãŠããç¡æ©æåã®å€§åã¯ãªã³é žã«ã«ã·ãŠ
ã ãã€ãŸãããããã·ã¢ãã¿ã¿ã€ãã®åœ¢ã§ååšã
ãããŸããææ©æåã¯äž»ãšããŠåäžã®çš®é¡ã®èçœ
質ãã€ãŸãã³ã©ãŒã²ã³ããæ§æãããããã¯åŒŸæ§
ãä¿æããŠéªšæ§é ãäžåœã«ããããªãã®ãé²æ¢ã
ãŠããããã¡ããéªšæ Œçµç¹ã¯çããŠããã®ã§ã骚
æ§é äžã«ã¯ä»£è¬æŽ»æ§ã®ããä»å çãªææ©æåãå
åšããªããã°ãªããããããã骚现èããã®æŽ»æ§
ãªä»£è¬ç©ãèªç¶æ²»çéçšãæ²»çã®ç¶æéçšã«å¯äž
ããŠããã ããããªããã骚ã®äž»æåã¯éçã«ã¯ã³ã©ãŒã²
ã³ãšã»ã©ããã¯ãªã®ã§ãåæ§ã®åã¯ç°ãªãã»ã©ã
ãã¯ææ䞊ã³ã«çš®ã ã®åã®ã³ã©ãŒã²ã³è£œå€ãå«ã
å€æ§ãªåæ§æã«ç§»æ€ç©ã䜿çšãããŠãããäŸã
ã°ãæïŒHayashiãK.ãet alãArc Orthop
Traumat SurgïŒ1982ïŒ99ïŒ265ãåã³ç±³åœç¹èš±ç¬¬
4314380å·ïŒãåç §ã®äºã 骚ã®ä¿®åŸ©ã¯æ¬¡ã®äºã€ã®ãã¡ã®ããããã®æ©æ§å
ã¯ããããçµã¿åããã€ãæ©æ§ã§èµ·ããããšãå€
ã€ãŠãããããªãã¡ãäŒå°ä¿®åŸ©
ïŒconductiverepairïŒã«ãããŠã¯æ¢ã«éªšçŽ°èãšã
ãŠã®ç¹æ§ãåãã现èïŒå骚现èïŒãè¿æ¥ãã骚
ããæ¬ é¥éšã®ç©ºéã«ç§»åãçŽæ¥éªšã圢æãããã
ã®å Žåã¯ïŒéç¹ç°çãªæ é€çŽ 以å€ã¯ïŒäœçç¹å¥ãª
å åã¯å¿ èŠãšããªããããããªãããèªå°ä¿®åŸ©
ïŒinduction repairïŒã«ãããŠã¯ãã®éçšã®åã«ã
ååããŠããªãè€æ°ã®å¯èœæ§ãæã€ã现èã®å骚
现èãžã®å€æããªããããå骚现èã¯å ãè»éªšã
圢æãããããç³ç°åãããŠå€è³ªã骚ã«å€ããã
ãã®æ§ã«ããèœåãåŸãããã«ã¯ç¹å®ã®èçœè³ªå
åãå¿ èŠãšããããããã®å åã®æ§è³ªã¯çŸæç¹ã§
ã¯ç解ãããŠããªããäŒå°ä¿®åŸ©ãèªå°ä¿®åŸ©ã®ãã
ãã«ã€ããŠãã宿䞻ã®çäœçµç¹ããæçµçãªéªšæ Œ
çµç¹ãæäŸãããå¿ èŠããããåŸã€ãŠããããã
éçšãåªä»ãã移æ€ç©ã¯ãæ¬ é¥ã®ãã骚ãé€å»ã
ãã骚ã®ä»£æ¿ç©ãšããŠåãã®ã§ã¯ãªãããããæ¬
ããŠããçµç¹ã®åçã掻æ§åããããã®åºè³ªçæ¯
æäœãšããŠåãã åŸã€ãŠããŸãã«ããããããšãç®çãšããŠãæ¬
é¥ã®ããéªšæ Œçµç¹çšåã¯éªšãæ¯ã®ç å·£çšã®ç§»æ€ç©
ãèæ¡ããè©Šã¿ããªãããŠããããããã®ç§»æ€ç©
ã¯æ¬ ããŠãã骚ã®çµæãæš¡å£ãããã®ã§ã¯ãªã
ãŠãæ§é çãªæ¯æäœãåã³æçµçã«é£æ¥ããæ°é®®
ãªéªšããçãã骚ã®æ²çç©ãåŸã ã«äŸµå ¥ãããæ¡
å åºè³ªãšããŠåããããããæ¯æäœã¯åã«åºè³ªç
æ¯æäœãšããŠã®æ©èœãæäŸããïŒã€ãŸããäŒå°ä¿®
埩ãåªä»ããïŒã ãã§ãªããçŸåšã骚圢æå åã
ïŒOFïŒåã¯ã骚圢æ çºçèçœè³ªãïŒBMPïŒãšããŠ
ç¥ãããŠãããã®ãä»äžããããšã«ãã€ãŠããã
ã«æªååã®çŽ°èã®å骚现èãžã®ååãä¿ãå åã
å«ãå Žåããããã³ã©ãŒã²ã³ã¯éªšã®æé·ã«äŒŽã代
è¬çã«çåå¯èœãªçŽ°èäžã§æ¢ã«è¯ãç¥ãããç©è³ª
ãªã®ã§ãèªå°ç骚修埩åã³äŒå°ç修埩ã®ãããã®
ç®çã®ããã«ãã倧éšåãã³ã©ãŒã²ã³ããæã移
æ€ç©ã䜿çšããè©Šã¿ããªãããŠããã èªå°ä¿®åŸ©ã«æçšãªç§»æ€ç©ã«ã€ããŠã¯ãç±³åœç¹èš±
第4294753ã«éªšåœ¢æ çºçèçœè³ªã®è£œé æ¹æ³ãé瀺
ãããŠãããæããåè¿°ã®ç¹èš±ã®BMPãšã¯ç°ãª
ããOFã®ç²Ÿè£œæ¹æ³ãç±³åœç¹èš±ç¬¬4434094å·ïŒ1984
幎ïŒæ28æ¥çºè¡ïŒã«é瀺ãããŠããããããã®å
åã¯éªšäžã䞊ã³ã«ç§»æ€çã®è£œé ã«äœ¿çšããæãã
ã¯ãã®å åãæå¹ãªåœ¢ã§æŸåºãããç¡æ©æåãé€
å»ãã骚ã®ç²å補å€äžã«å€©ç¶ã«ååšãããããã
ã®å åã¯ç²Ÿè£œåã³æªç²Ÿè£œã®åœ¢ã§å€ãã®ç§»æ€çã«äœ¿
çšãããŠããã ãŸããäŒå°ç骚修埩掻æ§ã®ããã®åºè³ªãšããŠã
ããªãã¡å现èã骚çºç现èã«æçãããããã®
å åãå«ãŸãåŸã€ãŠäŒå°ä¿®åŸ©ãåªä»ãã補å€ãšã
ãŠãã³ã©ãŒã²ã³è£œå€ã®ã¿ãå©çšããããšããè©Šã¿
ã«ã€ããŠé瀺ããç 究è ãããã ã¯ã¬ã±ã©ãŒïŒKrekelerãV.G.ãet alãJ.Oral
SurgïŒ1981ïŒ10ïŒSuppl.1ïŒ151ïŒã¯èªå·±ç±æ¥ã®æµ·
綿質ãã³ã©ãŒã²ã³è£œå€ïŒã³ã©ãŒã²ã³ããªãŒã¹ïŒå
æšåããã³ã¿ãã¢ãŒã 瀟ïŒãåã³çµåæ§ãŒã©ãã³
ã«ã€ããŠããŒã°ã«ç¬ã®æ¯æ ¹èæ¬ é¥çšå å¡«ç©ãšããŠ
ã®æå¹æ§ãæ¯èŒããããããã®è£œå€ã¯äººå·¥çã«èš
ãã骚ã®ç©ºæŽäžã«å·£ã«å å¡«ããççéçšãããªã¯
ãã é次ã©ããªã³ã°ã§è¿œè·¡ãããã³ã©ãŒã²ã³ããª
ãŒã¹ã¯ççãåªä»ããããšãå€ã€ãããèªå·±ç±æ¥
ã®æµ·ç¶¿è³ªç§»æ€çã«æ¯èŒãããšå¹æãå°ããã€ãã äžè¿°ã®è£œå€ã§çšããã³ã©ãŒã²ã³ããªãŒã¹ã¯è±ã®
ç®èããç±³åœç¹èš±ç¬¬4066083å·ã«é瀺ã®æ¹æ³ã«åŸ
ã€ãŠè£œé ãããã®ã§ãããè±ã®ç®èã现ããåå²
ããæŽå€ã§è±èåŸæŽæµããã次ãã§ããã·ã³ã§æ¶
åããŠç²çš ãªæžæ¿æ¶²ãšã飜å塩溶液ãå ããŠã³ã©
ãŒã²ã³ãæ²æ®¿ãããããã®æ²æ®¿ç©ãé žäžã«æžæ¿ã
ãåŸã塩溶液äžã«ç¹ç¶ç¶ã®çœè²æ²æ®¿ç©ãšããŠåæ²
殿ããããæ²æ®¿ç©ãå¿ èŠãªåæ°æŽæµããŠããã¢ã«
ã³ãŒã«æŽæµããŠè±å¡©ããã粟補ã³ã©ãŒã²ã³ãé žæº¶
液äžã«æžæ¿ããåçµä¹Ÿç¥ããããããγç·ç §å°ã§
æžèãããããã®å·¥çšã§è£œå€ãå£åãæ¶æ©ããå Ž
åãããããã®è£œå€ã¯ã³ã©ãŒã²ã³ããªãŒã¹
ïŒCollagen fleeceïŒã®å称ã§åžè²©ãããäœä»¶ãã®
ä»ã®éªšã®ä¿®åŸ©ã®ç 究ã«äœ¿çšãããŠããã ãžãšãŒãºçïŒJoosãU.ãet alãBiomaterials
ïŒ1980ïŒïŒïŒ23ã26ïŒã³ã©ãŒã²ã³ããªãŒã¹ã人工
çã«å·ã€ãããŠãµã®ã®äžé¡éªšã®ç§»æ€çãšããŠå©çš
ããïŒé±éåŸã«æ¬ é¥ã網ç¶ã®éªšç²ã§æºããããïŒ
é±éåŸã«ã¯å®å šã«éªšåããããšãèŠåºããããŒã
ããã³çïŒZetzmannãD.ãet alãSchweiz
Mschr SabnhelikïŒ1982ïŒ92ïŒ119ïŒãã³ã©ãŒã²
ã³ããªãŒã¹ã移æ€çãšããŠçšããŠé¡é¢å€ç§ã«ãã
ã骚ã®åçã«æåãããã¹ããªã³ãŽã©ã ç
ïŒSpringorumãH.W.ãet alãZ.OrthopïŒ1977ïŒ
115ïŒ686ïŒã¯ã³ã©ãŒã²ã³ããªãŒã¹ãç®è³ªå±€ã®æ¬ é¥
ã«çšããŠåæ§ã®çµæãåŸãã ãžã€ãã€çïŒJaffeeãA.ãet alãArchs Oral
BiolïŒ1978ïŒ23ïŒ415ïŒibid.ïŒ1982ïŒ27ïŒ999ïŒã¯ç¬
ã®ç®èããé ¢é žæœåºãããªã¯ããé ¢é žïŒãšã¿ããŒ
ã«ã§ç²Ÿè£œããŠè£œé ããã³ã©ãŒã²ã³æº¶æ¶²ã䜿ã€ãŠã
ç¬ã«ãããã¢ã¯ãªã«é žæš¹èæ¯ç§»æ€çã®åºå®ã«æå
ããããšãå ±åããŠãããåºå®ã«æåãã移æ€ç
ã¯ïŒå¹ŽåŸã«ãæãããªãã€ãã ã¯ãŠã·ã³çïŒCucinããL.ãet alãNew
York State Journal of MedecineïŒ1979ïŒ1856ïŒ
ã¯ãγç·ç §å°ãããåçã®ç®èããã®ã¢ãããã
ããã»ã³ã©ãŒã²ã³ããŠãµã®ã®å©éªšã®ä¿®åŸ©ã«äœ¿çšã
ãããŸãããŒã©ãã³ç¶ã¹ãã³ãžææåã¯èªå·±ç±æ¥
ã®éªšç²ã§æ¯æããŠãç¬ã®é èã®ç©Žã®ä¿®åŸ©ã«äœ¿çšã
ãã æãããããããããå«ãã ãŸãŸã§ãγç·ç §å°
ã«ããæ¶æ©ããã³ã©ãŒã²ã³è£œå€ã®æ¯é«è ã®å å¡«å
ã³ç®äžã骚代çšã移æ€çãšããŠã®å©çšããããã
ãEPå ¬é0012443ïŒ1980幎ïŒæ25æ¥ïŒåã³EPå ¬é
0012959ïŒ1980幎ïŒæïŒæ¥ïŒã§é瀺ãããŠããã 解決ãã¹ãåé¡ç¹ïŒœ äžè¿°ã®ã³ã©ãŒã²ã³ä¿®åŸ©æ¹æ³ã¯ããããå®å šã«ã¯
æåããŠããããççãèµ·ãããïŒç¹ã«è¢«ç§»æ€éš
ãšç°çš®ã®ã³ã©ãŒã²ã³ãçšããå ŽåïŒççãäžå®å š
ã ã€ãããããæ¬çºæã¯äžè¿°ã®æ¬ ç¹ã解æ¶ããã
ãšãåºæ¬ç®çãšããå æ¹ã«æé·ãã骚修埩çµç¹
ããæå®ã®éªšçŽ°èãã修埩ãæãŸããæ¬ é¥ã«äŒé
ãåŸã移æ€å¯èœãªã³ã©ãŒã²ã³è£œå€ãæäŸããããš
ã課é¡ãšããã çºæã®é瀺 æ¬çºæã¯ã被移æ€éšãšã¯ç°çš®ã®ã³ã©ãŒã²ã³ã䜿
çšå¯èœãªãããå€éã«å ¥æããããšãã§ãã極ã
ãŠå¿çšæ§ãåºããããã«ãæ¬çºæã¯èå¿åæ§ãèŠ
æ±ãããåºç¯å²ã®çšéã«å¯ŸããŠæ¥µããŠé©çšæ§ãé«
ãã æ¬çºæã¯æ¬ é¥ã«ãïŒå¿ èŠã§ããã°ïŒä¿®åŸ©ããã
åŽãšã¯ç°çš®ã®çç©ããåŸãã粟補éå ç«åæ§ã³ã©
ãŒã²ã³ã移æ€ããããšã«ãã€ãŠåºä¹³é¡ïŒç¹ã«äºº
éïŒã®éªšã®æ¬ é¥ã修埩ããããéªšæ Œåºè³ªãåçã
ããããããã®ã³ã©ãŒã²ã³è£œå€ãæäŸãããåŸã€
ãŠãæ¬çºæã¯é«åºŠã«ç²Ÿè£œãããæ°ãã骚ã®çé·ã®
ããã®åºè³ªãæäŸãåŸãæ±çšã³ã©ãŒã²ã³è£œå€ã䜿
ã€ãŠçäœçµç¹ã®éªšã®æ¬ é¥ã®èªç¶ãªä¿®åŸ©æ©æ§ãåªä»
ããæ¹æ³ãæäŸããã æ¬çºæã«ãããŠã¯ãçããŠããå骚现è
ïŒosteoprogenitor cellïŒãå«ãæ°é®®ãªéªšãæ¬ é¥éš
ã«é²åºããããã骚åã³ç®èã®ããããåã¯äž¡æ¹
ããåŸãçµæç©ã§ããã³ã©ãŒã²ã³è£œå€ãšæ¥è§Šãã
ãã骚起æºã®ã³ã©ãŒã²ã³ã¯ç¡æ©æåãé€å»ãã骚
ïŒDMBïŒãã補é ãããããããããäºå®äžé€
å»ããåããå®è³ªçã«æ§æããããããã¯ãèª
å°ä¿®åŸ©ãåªä»ããå åãç Žå£ãããã€ããããã
ããé€å»ããããªãã·ã³çã®ã³ã©ãŒã²ã³éå解æ§
ã®èçœè³ªåè§£é µçŽ ã§DMBãåŠçããŠè£œé ããã
ãã®ç©è³ªã¯ç²æ«ç¶ã§åŸããã骚ã³ã©ãŒã²ã³ç²æ«
ïŒBCPïŒãšèšããç®èèµ·æºã®ã³ã©ãŒã²ã³ã¯äž»ãšã
ãŠåã³ã©ãŒã²ã³ã§å°éã®åãå«ã¿ãå žåçã«
ã¯åçã®ç®èããåŸãããããã®åã®ã³ã©ãŒã²ã³
ã¯ã¶ã€ããŒã ïŒZydermãåæšåïŒã³ã©ãŒã²ã³ç§»
æ€ç©ãšããå称ã§åžè²©ãããŠãããZCIãå žåãš
ãããã®ã³ã©ãŒã²ã³è£œå€ã¯åæ§æããã埮ç¹ç¶ç¶
ã®ã¢ããããããã³ã©ãŒã²ã³ã§ãããããã«ãç®
èèµ·æºã®ã³ã©ãŒã²ã³è£œå€ã¯ç§»æ€ããåã«åçµä¹Ÿç¥
ããããšãã§ããã ãããã®ããããã®æ··åç©ã®BCPãšZCIã®æ¯ã
å€åãããããšã«ãã€ãŠä¿®åŸ©ææã®ç©æ§ã調ç¯
ããæ¬ é¥ã®ç¹å®ã®èŠæ±ãåšå²ç°å¢ã«é©å¿ãããã
ãšãã§ããã åŸã€ãŠæ¬çºæã¯äžã€ã®èŠç¹ã«ãããŠã(a)çããŠ
ããå骚现èãæããæ°é®®ãªéªšã®è¡šé¢ãæ¬ é¥éšã«
é²åºãã(b)åèšæ¬ é¥éšã«ã³ã©ãŒã²ã³è£œå€ãå å¡«ã
æ°é®®ãªéªšã®è¡šé¢ãšæ¥è§Šãããããšããæã骚ã®æ¬
é¥ã®ä¿®åŸ©æ¹æ³ã«é¢ãããåèšã³ã©ãŒã²ã³è£œå€ã¯ç²Ÿ
補åæ§æã¢ãããããã埮ç¹ç¶ç¶ç®èã³ã©ãŒã²ã³
åã¯éªšã³ã©ãŒã²ã³ç²æ«ïŒåèšããå®çŸ©ã®éãïŒã
æãã¯ãããã®æ··åç©ã§ããã 粟補åæ§æ埮ç¹ç¶ç¶ã³ã©ãŒã²ã³ã¯åçµä¹Ÿç¥äœã§
ãè¯ãããã®åçµä¹Ÿç¥è£œå€ïŒåçµä¹Ÿç¥ã³ã©ãŒã²ã³
ã²ã«åã¯LCGïŒã¯åãæ±ãæãå§å»¶ãããã¯æ³š
åããŠæ¿ç¶ã«ããããšãã§ããããã¯å®¹æã«ç§»æ€
ç©ïŒçïŒãšããŠå©çšã§ããã ç®èèµ·æºã®ã³ã©ãŒã²ã³ã¯å žåçã«ã¯ç®èããã
å¯æº¶å圢æ ãžã®è§£é¢ããéã«ããæ» èãåã³ãã
ããããé€å»åŸã®åŸ®ç¹ç¶åœ¢æ ãžã®åæ§æãšããå·¥
çšãçµãŠè£œé ããã代衚çãªè£œå€ã¯è»éšçµç¹ã®ä¿®
埩ã«æçšã ãšèšèŒãããŠããããã®ç®çã®ããã«
ã¶ã€ããŒã ã»ã³ã©ãŒã²ã³ç§»æ€ç©ïŒZCIïŒã®åã§åž
販ãããŠãããããã®è£œé æ¹æ³ã¯ç±³åœç¹èš±ç¬¬
3949073å·ã«è©³çŽ°ã«èšèŒãããŠããã 骚ã³ã©ãŒã²ã³ç²æ«ã¯ç¡æ©æåãé€å»ãã骚
ïŒDMBïŒããåŸãããå®è³ªçã«ããããããã
ãé€å»ãããåã³ã©ãŒã²ã³ããæããããã¯
DMBãããªãã·ã³ã§åŠçããŠè£œé ãããããªã
ã·ã³ã¯éªšåœ¢æåã³ããããããã«é¢é£ããå åã
å ±ã«ç Žå£ããããã®æ¹æ³ã«ãã€ãŠåŸããã骚ã³ã©
ãŒã²ã³ç²æ«ïŒBCPïŒã¯äžè¿°ã®å¥œãŸããæ§è³ªãšå ±
ã«èå¿åæ§ãæããéªšæ Œã®æ¬ é¥çšã®è² è·æ¯æäœãš
ãªãã æ¬çºæã¯å¥ã®è«žèŠç¹ã«ãããŠã¯ãæ¬çºæã«æçš
ãªã³ã©ãŒã²ã³è£œå€åã³ãã®è£œé æ¹æ³ã«é¢ããã çºæã®å®æœæ æ§ïŒœ  å®çŸ© æ¬æ现æžã«ãããŠã骚ã®æ¬ é¥ã®ãäŒå°ã
ïŒconductiveïŒä¿®åŸ©ãšã¯æ¬ ããŠãã骚ãè£å ã
ããéçšåã¯ææã®æ°ãã骚ãæé·ããéçšã®
ããšãèšããåºãæ什ãåããïŒcommittedã
å³ã¡ååããïŒå骚现èïŒosteoprogenitor
cellïŒã®ä»£è¬ãå«ãããããã®çŽ°èã¯ãäžè¬ã«
骚圢ææ§åã¯åœ¢æ çºçæ§èçœå åãšããŠç¥ãã
ãèçœå åã«ããèªå°ãªãã«è»éªšåã³ïŒåã¯éªš
ãçæããããšãã§ãããã®éçšã¯ååãã现
èã«ãã€ãŠéªšåœ¢çãçŽæ¥çã«è¡ãããæ©èœãå«
ãããååãã现èã®çæã«èçœå åã®æ·»å ã¯
å¿ èŠãšããªãã æªååã®çŽ°èã®å骚现èãžã®å€åã¯çäœã«åº
æã®èçœè³ªã«ãã€ãŠãè¡ããåŸãããšã¯ç解ã
ãããããããããã§å®çŸ©ãããäŒå°æ§ã骚修
埩ã¯å€éšããäŸçµŠãããæ¯æåºè³ªã®ã¿ã«ãã€ãŠ
åªä»ããããã®ã§ãç°çš®ã®çäœçµç¹ãéå åšç
ãªéªšåœ¢æå åã¯æäŸããªãã ã骚ã®æ¬ é¥ããšã¯éªšçµç¹ã®ä»çãæãŸãã骚
æ Œçµç¹ã®ééã®ããšã§ããã®ééã¯çäœã«å¯Ÿã
ãå·å®³ãããã¯çäœã®éªšæ Œçµç¹ã®å 倩æ§ç°åžžå
ã¯å£åã«ãã€ãŠçãããããããæ¬ é¥ã¯åãªã
骚æãç æ°ã«ãã骚çµç¹ã®åŽ©å£ãç æ°ã®éªšçµç¹
åã¯æãŸãããªãå 倩æ§ç°åžžã®å€ç§çãªé€å»ã
æãã¯æŽåœ¢å€ç§åã¯çŸå®¹å€ç§ã®çµæãšããŠçã
ãããšãããã ãæ°é®®ãªéªšããšã¯å¥åº·ãªç¶æ ã«ãããåéã
ãŠçäœçµç¹ãé²åºããããšçã«ãã€ãŠåŠçãã
ãçäœçµç¹ã®éªšæ Œç³»äžã®éªšã®ããšãèšããæ¬çº
æã®æ¹æ³ã«ãããŠæ¬ é¥éšã®éªšã®åççšã«çããŠ
ãã现èãæäŸããããã«ã¯ãæ°é®®ãªéªšãæ¬ é¥
éšã«æ¥è§Šãããå¿ èŠãããããšãå€ã€ãŠããã ãã³ã©ãŒã²ã³è£œå€ããšã¯äž»æåãšããŠããçš®
ã®ã³ã©ãŒã²ã³èçœè³ªãå«ãçµæç©ãèšãã ãç°çš®ã®ãïŒxenogeneicïŒãšã¯æ²»çãããç
äœäžã®çš®ïŒspeciesïŒãšã¯ç°ãªãçš®ã«ã€ããŠèš
ãã ãäžçŽç©ãå«ãŸãªããåã¯ã粟補ãããããš
ã¯èªç¶ç¶æ ã§ã³ã©ãŒã²ã³çã®è£œå€äžã«é垞䌎ã
ããäžçŽç©ã®ååšããªãããšãèšããããªã
ã¡ãåçã®ç®èãã調補ããã³ã©ãŒã²ã³ã¯ãå
çã®ç®è以å€ã®æåãå®è³ªçã«é€å»ããŠããŸã
ã°äžçŽç©ãå«ãŸãã骚ããã®ã³ã©ãŒã²ã³è£œå€ã«
ã€ããŠèšãã°éªšä»¥å€ã®æåãé€å»ããã°äžçŽç©
ãå«ãŸãªãããšã«ãªãã ãåæ§æïŒreconstitutedïŒãã³ã©ãŒã²ã³ãšã¯
ïŒæ¬ãããç¶ã®ååããããããã䌞é·éšãä»
ããç¶æ åã¯ä»ããŠããªãç¶æ ã§å¥ã ã«åé¢ã
ãŠæº¶æ¶²äžã«å°å ¥ãã次ãã§åŸ®ç¹ç¶ç¶
ïŒfibrillarïŒã«åæ§æããã³ã©ãŒã²ã³ã®ããšã
èšãããã®åœ¢ç¶ã«ãããŠåŸ®ç¹ç¶ã¯çŽ°é·ãã³ã©ãŒ
ã²ã³ååããæããçžäºã«ããããç¶ã«éãªã
åã€ãŠé·ãã®çŽ1/4ã®å¹ ãæããããã®çµæã
垯ç¶æ§é ããªããããã«åéããŠç¹ç¶ç¶ã«ãªã
ããšãã§ããã ãå®è³ªçã«æ¶æ©ããªãããšã¯ããããããã
é€å»ãæ¬æ¥ã®æ¶æ©åœ¢æèœåãæ¬ ã補å€ãšããã³
ã©ãŒã²ã³ã«ã€ããŠããããã®æ§ãªè£œå€ã¯ãäŸã
ã°ã°ã«ã¿ã«ã¢ã«ãããåŠçããããããããçµ
åã®æ¬äŒŒçãªåœ¢æ ã圢æãããããªåŠçãè¡ã
ããšã«ãã€ãŠæå³çã«æ¶æ©ãããªãéãå®è³ªç
ã«æ¶æ©ããªããäŸãã°é«æž©ãγç·ç §å°çã®æ» è
ãç®çãšããŠãã°ãã°è¡ãããåŠçã«ãããã
ããç¶ååéã«ä»å çã«æ¶æ©ã圢æããããæ¬
çºæã«äœ¿çšããã補å€ã§ã¯ãç®èèµ·æºã®ã³ã©ãŒ
ã²ã³ã溶液äžã«åæ£ãããŸãŸã®ç¶æ ã§åŸ®çŽ°ãé
ïŒmicrofiltrationïŒããŠæ» èããåŸæ» èæ¡ä»¶äž
ã§åŠçããã®ã§æãŸãããªãæ¶æ©ã®åœ¢æãåé¿
ãããã ã骚ã³ã©ãŒã²ã³ç²æ«ãïŒBCPïŒãšã¯ç¡æ©æå
ãé€å»ãã骚起æºã®ã³ã©ãŒã²ã³ã®ç²Ÿè£œã¢ããã
ããã補å€ãèšãããã®è£œå€ã¯å®è³ªçã«ã³ã©ãŒ
ã²ã³èªäœããæãã代è¬çã«æŽ»æ§ãªèçœè³ªãå«
ãŸãªããããã¯éªšç±æ¥ãªã®ã§åã³ã©ãŒã²ã³ã
ãæãã骚ã«ãããŠèŠãããåºæã®ïŒæ¬¡å æ§é
ãšè¯ã䌌ãæ§é ãæã€ã  詳现ãªèª¬æ B1 é©çš æ¬çºæãé©çšããã骚ã®æ¬ é¥ã«ã¯ãéªšæ Œçµ
ç¹ãå®å šåããããã«å å¡«ããå¿ èŠããã骚
çµç¹äžã®ç©ºæãå«ãŸãããæ¬çºæã®æ¹æ³ã®é©
çšæ段ãšããŠé©åœãªéªšæ¬ é¥ä¿®åŸ©ã®å»åŠçåã¯
ç£å»åŠçãªæ¹æ³ã«ã¯ãæŽåœ¢å€ç§ãç æ°ã®éªšçµ
ç¹ã®é€å»äžŠã³ã«éãåããåã¯è£ãŠã€ã«ãã
è£å ããããã æ¯ã®åºå®ãæ¯ã®è£å ãå€å·ã®
修埩çããããæ¬çºæã®ã³ã©ãŒã²ã³è£œå€ã®ç
確ãªé©çšæ¹æ³ã¯ãåœæ¥è ã«ç解ãããéãã
骚ã®æ¬ é¥ã®æ§è³ªäžŠã³ã«éžæããæ²»çæ³ã«ãã€
ãŠå€åãããããããªããäžè¬çã«ã¯ãæ¬çº
æã®çµæç©ã¯ããŒã¹ãç¶åã¯ã²ã«ç¶ãšãªãã
ããŒã¹ããæ¬ é¥éšã«å€ç§çã«å å¡«ããŠæ¬ é¥éš
ã®åœ¢ç¶ã«æ圢ããããšãã§ãããæ¬çºæã®ã³
ã©ãŒã²ã³è£œå€ã¯ããŸããæ··åããŠããåžèãª
æžæ¿æ¶²ãšããã°æ¬ é¥éšã«æ³šå ¥ããããšãã§ã
ããã ãããããã®å Žåãæ²»çãã¹ãæ¬ é¥éš
ã¯å ãæŽæµããŠæ°é®®ãªéªšã®è¡šé¢ãé²åºããã
çããŠãã骚现èãæ¬ é¥éšãšé£éããããã«
ããªããã°ãªããªããæ°é®®ãªéªšã®è¡šé¢ã¯ãæ
ä¹ çãªéªšæ§é ã®åæã«èŠãã骚å现èãåŸã
ããã«å¿ èŠãšãªãã B2 ã³ã©ãŒã²ã³è£œå€ 倩ç¶ã³ã©ãŒã²ã³ã¯å€§éšåãäžéãããæ§é
ããæãããã®ãããæ§é ã¯ã°ãªã·ã³ãïŒçš®
é¡ã®ã¢ããé žïŒéåžžããããªã³åã³ãããã
ã·ãããªã³ïŒã«çµåããããªãã¬ããã·ãŒã±
ã³ã¹ã®ç¹°ãè¿ããå«ã¿ãåŸã€ãŠã°ãªã·ã³ãé
äžã§ïŒåç®ããšã«çŸãããããã«ãå šãŠã®ã³
ã©ãŒã²ã³éã®å端æ«ã«ã¯ãã°ãªã·ã³ã®ããªã
ã¬ããã·ãŒã±ã³ã¹ãå«ãŸããããç¶ã§ãªãé
åãååšããããããã®é åã¯å€§æµã®ã³ã©ãŒ
ã²ã³è£œå€ã«äŒŽãå ç«åæ§ã«é¢é£ãããã®ãšè
ãããããå ç«åæ§ã¯ãããããé åãé€å»
ããŠãã¢ãããããããã³ã©ãŒã²ã³ãšããã
ãšã«ãã€ãŠå€§æ¹æ¶å»ã§ãããããã¯ããªãã
ã·ã³åã¯ããã·ã³çã®èçœè³ªåè§£é µçŽ ã«ãã
æ¶åã«ãã€ãŠéæã§ãããããããèçœè³ªå
è§£é µçŽ ã®ç¹ç°æ§ã®éãã®ããããããããé€
å»ã®å®å šãã«å·®ãçãããåŸã€ãŠæãå®å šã«
é€å»ãåŸãç¹å®ã®èçœè³ªåè§£é µçŽ ã奜ãŸã
ããããããé µçŽ ãšããŠããªãã·ã³ãããã
ããã¯å®è³ªçã«å šãŠã®ããããããéšãé€å»
ããããšãã§ããã éãããç¶ã®ããããããé åã¯æ¶æ©ã圢
æããŠåŸ®ç¹ç¶æ§é ãå®å®åããããã«ãå¿ èŠ
ã§ããããããã®é åã¯ãªãžã³æ®åºã«æ¶æ©å¯
èœãªã¢ã«ãããé¡ãå«ããå¿ èŠãªå Žåã¯ãã¢
ããããããã³ã©ãŒã²ã³ã¯äººå·¥çã«æ¶æ©ããª
ããã°ãªããªãã å šãŠã®ã³ã©ãŒã²ã³ã¯äžè¿°ã®ç¹æ§ãå ±æãã
ããã³ã©ãŒã²ã³ã¯äžéãããã®åã ã®éã«ã
ããã¢ããé žã®æ£ç¢ºãªé åºãçæ°Žåç©å«éã
åã³ãžã¹ã«ãã€ãæ¶æ©ã®ååšã®æç¡ã«åºã¥ã
ãŠçŽ10çš®é¡ã«å¯åé¡ãããŠãããæãæ®éã®
äºåã¯ååã³åã§ãåã¯ç®èãè ±åã³
骚äžã«ååšãç¹ç¶èœçŽ°èãã圢æãããããŸ
ããåã¯äž»ã«ç®èäžã«ååšãããä»ã®åã¯
ç¹æ®ãªèåã¯è»éªšããããã¯çŽ°èè¡šé¢ã«ååš
ãããååã³åã¯ãã®ãããäžã«åæ°ã®
ã¢ããé žãå«ãããäžéãããã®ïŒ£ç«¯æ«ã«è¿
æ¥ããïŒåã®ã·ã¹ãã€ã³ãå«ã¿ããã§å éšç
ã«æ¶æ©ãåŸãããåã¯ãããå«ãŸãªãã åã³ã©ãŒã²ã³ã¯ïŒæ¬ã®Î±2ïŒïŒéãšïŒæ¬
ã®Î±1ïŒïŒéãå«ã¿ããã®åã ããã®äžéã®
é åã«1014ã®ã¢ããé žãå«ãããŸããåã ã®
éäžã«ã¯æ°åã®çæ°Žåç©æåãååšããã
åã³ã©ãŒã²ã³ã¯Î±1ïŒïŒïŒïŒæ¬ã®éïŒããå«
ãŸãããããã¯ãã®äžéãããé åã«1026ã®
æ®åºãå«ããåè¿°ã®ããã«ãåã³ã©ãŒã²ã³
ã®äžéé åã®ã«ã«ããã·ç«¯æ«ã«ããäžå¯Ÿã®è¿
æ¥ã·ã¹ãã€ã³ã«ããå éšæ¶æ©ãå®å®åãã
ãããããã®ã³ã©ãŒã²ã³ãçãéäžéããã
ç¶ã®ç«¯éšïŒããããããïŒãå«ããæ¬çºæã«
çšããåæ§æ埮ç¹ç¶ç¶ã¢ããããããã³ã©ãŒ
ã²ã³ã¯ååã³åã®äž¡æ¹ã®ã¢ãããããã
圢æ ãå«ããã骚ã³ã©ãŒã²ã³ç²æ«ã¯å°ãå
ã®ã¢ãããããã圢æ ããæãã ç®èèµ·æºã³ã©ãŒã²ã³ æ¬çºæã®çµæç©ãšããŠæçšãªã¢ããããã
ãåæ§æ埮ç¹ç¶ç¶ç®èã³ã©ãŒã²ã³è£œå€ã®ä»£è¡š
çãªãã®ãšããŠãéåžžåååã¶ã€ããŒã
ïŒZYDERMïŒã»ã³ã©ãŒã²ã³ç§»æ€ç©ïŒZCIïŒãš
ããŠè²©å£²ãããŠããã粟補åçç®èèµ·æºã¢ã
ãããããã³ã©ãŒã²ã³åæ§æ埮ç¹ç¶ç¶æžæ¿ç©
ãããã ããåã³ä»ã®ç®èèµ·æºç²Ÿè£œã¢ãããããã
åæ§æ埮ç¹ç¶ç¶ã³ã©ãŒã²ã³ã¯åœæ¥è ã«è¯ãç¥
ãããŠãããZCIã¯ããåããç®èçŽäžãžã®
補å€ã®æ³šå ¥ã«ããå¹ãã å·å®³éšã®ä¿®åŸ©ãå§ã
ãšããŠãè»éšçµç¹ã«åºãå©çšãããŠãããã
ãããªããããã®æ§ãªè£œå€ã¯ãOFããå«ã¿
èªå°ç骚修埩ãç®çãšããæ¯æææãšã®é¢é£
䜿çšãé€ããšã骚ã®ä¿®åŸ©ã«ã¯äœ¿çšãããŠããª
ããããããå¿çšäŸã¯ç±³åœç¹èš±åºé¡çªå·
348414ïŒ1982幎ïŒæ12æ¥åºé¡ïŒã«é瀺ãããŠ
ããã ãã®ã³ã©ãŒã²ã³è£œå€ã¯åçã®ç®èããåŸã
ãã®ãªã®ã§ãäž»ãšããŠåã³ã©ãŒã²ã³ãšçŽïŒ
ãïŒïŒ ã®åã³ã©ãŒã²ã³ãå«ããã¢ãããã
ããã³ã©ãŒã²ã³ã¯é©åœãªãéæè¡ã䜿ã€ãŠæº¶
液äžã«æžæ¿ãããŸãŸã®ç¶æ ã§æ» èãããã®ã§
å£åãæ¶æ©ãçããªããããã埮ç¹ç¶ç¶ã«å
æ§æãæ» èæ¡ä»¶äžã§å è£ ããã åçµä¹Ÿç¥ç®èã³ã©ãŒã²ã³ ãã®ã³ã©ãŒã²ã³ãåçµä¹Ÿç¥ããŠåçµä¹Ÿç¥ã³
ã©ãŒã²ã³ã²ã«ïŒLCGïŒãšãããšã移æ€åã¯
å å¡«ããã空æäžã«ãã€ãããšåºå®åããåª
ããæ§é ä¿ææ§ã«ããææã®äœçœ®ããã®ç§»å
ã«æµæããèœåã瀺ããããã«ãLCGãã
ãªãã¯ã¹ã¯ç§»æ€éšåãžã®éªšçµç¹ã®çåãåç
é·ãæ¯æãããšããæãŸããããã€å¿ èŠãªæ§
質ã瀺ããåŸã«ãã詳现ã«èª¬æããæ§ã«ãæ¬
çºæã®LCG補å€ã¯PHãåçµé床ãåã³åçµ
æã®æžæ¿æ¶²ã®æ¿åºŠãå¶åŸ¡ããŠåºç¯ãªç©æ§ãåŸ
ãããšãã§ãããææããç¹æ§ã«ãããã
ããæ¬çºæã®LCG補å€ã®ç¹åŸŽã®äžéšã¯ãå®
質çã«äžçŽç©ãå«ãŸãªãã¢ããããããåæ§
æ埮ç¹ç¶ç¶ã³ã©ãŒã²ã³ããæãããšã«ããã
ãã®è£œå€ã埮现ãéã«ãã€ãŠæ» èåŸãæ» èæ¡
件äžã§åŠçããŠãããã¯ãæ¶æ©ã¯å®è³ªçã«å
åšããªããä»å çã«åçµä¹Ÿç¥åŠçãããšãã
ãç¶ã«ãªããã¯ãã¿åã¯éãåç©ã䜿ãã ã
ã§ç°¡åã«åæããŠå»ççšã®é©åœãªåœ¢ç¶ã«ãã
ããšãã§ããã»ã©ã®çµååã瀺ãããã®ãã
ããæ¿¡ãããšããç¶ã®ææãåŸãããããã¯
ä»»æã®åœ¢ç¶ã«æ圢ããŠæ¬ é¥éšã«æ¿å ¥ããããš
ãã§ããã ä»ã®åœ¢æ ã®å»ççšåçµä¹Ÿç¥ã³ã©ãŒã²ã³ã«ã€
ããŠãé瀺ãããŠãããããããã¯æ¬çºæã®
ã³ã©ãŒã²ã³è£œå€ãšã¯ç°ãªããããã¹ã¿
ïŒBattistaãç±³åœç¹èš±ç¬¬3471598å·ïŒã¯çã®ç®
èãå¡©é žã§åŠçããŠèšæœ€åŸã³ã©ãŒã²ã³ç¹ç¶ã
åé¢ããŠåŸãããäžéçãªåŸ®çµæ¶åœ¢æ ã®ã³ã©
ãŒã²ã³è£œå€ã®åçµä¹Ÿç¥äœãé瀺ããŠãããã
ã®ã³ã©ãŒã²ã³ã¯ç²Ÿè£œããŠãããããã¬ããã
ããé€å»ããŠããªãããã®æ§ã«ããŠè£œé ãã
ææã¯åžæ°Žæ§ã¹ãã³ãžãšããŠé©ããããäžçŽ
ç©ãå«ã¿å ç«åæ§ãæãããããæããã«çŽ
æ¥çãªå»ççšã«ã¯é©ããªããããã«ããã®äž
éç圢æ ã®è£œé ã«çšããé žãã¹ãã³ãžäžã«æ®
åãããã¯ã³ãçïŒKuntz et alãç±³åœç¹èš±
第3368911å·ïŒã¯ãé žãæ®åããªãããã«ã
ãã¹ã¿ã®äœ¿çšããæ¯èŒçäžæ®çºæ§ã®é žã®ä»£ã
ãã«ã«ã«ãã³é žãçšããåžæ°Žæ§ã³ã©ãŒã²ã³ã¹
ãã³ãžã®è£œé æ¹æ³ãé瀺ããããã®è£œå€ã«ã¯
å®è³ªçã«çŽç²ãªã³ã©ãŒã²ã³ç¹ç¶ãçšããããš
ãé瀺ãããŠãããããã¬ããããã¯é€å»ã
ãŠããªããå®®ç°ïŒMiyataãç±³åœç¹èš±ç¬¬
4294241å·ïŒã¯ç®èå 垯çšã®åçµä¹Ÿç¥ã³ã©ãŒ
ã²ã³ã·ãŒããé瀺ããŠããããã®ã·ãŒãã¯åŸ®
ç¹ç¶ç¶ã«åæ§æããã¢ããããããã³ã©ãŒã²
ã³ãã補é ãããããæ¬çºæã®LCGãšã¯ã
ããã人工çã«æ¶æ©ãããŠããç¹ã§ç°ãªãã
ãªãŒã¹ïŒRiesãç±³åœç¹èš±ç¬¬4066083å·ïŒã¯ã
å·ã®æ²»ççšã®åžè²©è£œåãã³ã©ãŒã²ã³ããªãŒã¹
ïŒCollagen fleeceãåæšåïŒã®è£œé æ¹æ³ãé
瀺ããŠãããã©ãã¯ãšãããšã«ã¹ïŒLuckã
Danielsãç±³åœç¹èš±ç¬¬4233360å·ïŒã¯åçµä¹Ÿç¥
補å€ã«ã€ããŠèšèŒããŠããããããã¯æ¬çºæ
ã®ãããªãããã§ã¯ãªãçºæ³¡äœã«ãªãã æ¬çºæã®LCGã¯éåžžã粟補åæ§æ埮ç¹ç¶
ç¶ã¢ããããããã³ã©ãŒã²ã³ãäŸãã°ã¶ã€ã
ãŒã ïŒZydermïŒã³ã©ãŒã²ã³ç§»æ€ç©åã¯ã¶
ã€ããŒã ã³ã©ãŒã²ã³ç§»æ€ç©ïŒå ±ã«çã®ç®è
ãã補é ããåæ§æã³ã©ãŒã²ã³è£œå€ã®åæš
åïŒãã補é ããããä»ã®åæ§æ粟補ç®èã³
ã©ãŒã²ã³åæãäŸãã°ä»ã®åºä¹³åç©ã®ç®èã
çšããããšãã§ãããããããããã®å Žå
ããåºçºææã¯ãå¯æº¶åãã圢æ ããåæ§æ
ããå®è³ªçã«çŽç²ãªã³ã©ãŒã²ã³åŸ®ç¹ç¶ãšãã
å·¥çšã«ãã€ãŠããããã®åæãã補é ããªã
ãã°ãªããªããããã«ãããããããã¯é©åœ
ãªå·¥çšãäŸãã°ããªãã·ã³æ¶åçã«ãã€ãŠé€
å»ããªããã°ãªããªããå žåçã«ã¯ãããã
粟補補å€ã¯åºçºææã埮现ã«åå²åŸãé žçŽ å
ã³ïŒåã¯é©åœãªPHæ¡ä»¶äžã§éã³ã©ãŒã²ã³ç©è³ª
ãç Žå£åã¯æœåºããç¶ããŠã³ã©ãŒã²ã³ãããª
ãã·ã³çã®æ¶åæ§é µçŽ ã§åŠçããŠããããã
ããé€å»ãã埮现ãéããŠæ» èããPHåã³å¡©
æ¿åºŠãé©åœã«èª¿ç¯ããŠïŒã€ãŸããé žæ§ããäž
æ§ã§ïŒã³ã©ãŒã²ã³åŸ®ç¹ç¶ãåæ§æããŠè£œé ã
ãããã®æ§ãªè£œå€ã¯åœæ¥è ã«ç¥ãããŠããã
äºå®ããããçšãã補åãåžè²©ãããŠããã åçµä¹Ÿç¥åœ¢æ ã®è£œé ãžã®åæ§æã³ã©ãŒã²ã³
ã®äœ¿çšã¯ãæ» èéçšã§ã®å£åé²æ¢ã®èŠ³ç¹ãã
ãéèŠã§ãããã³ã©ãŒã²ã³ã¯è£œé éçšã®äžæ®µ
éã§å¯æº¶å圢ããšããã埮现ãéãå¯èœã§ã
ãã®å·¥çšã¯å®å šã«äžæ§ã®å·¥çšãªã®ã§æ§é ã«é¡
èãªååŠçãç©ççãªå€åãçããªãã以åŸ
ã®å·¥çšãæ» èç¶æ ã§å®æœããã°ããã以äžã¯
æ» èãå¿ èŠãšããªãã®ã§ãçæç©ã«å ç±åã¯
γç·ç §å°çã®ããéé ·ãªæ» èæ¡ä»¶ãçšããå Ž
åã«çããæ§ãªå£åãæ¶æ©ãçããªãã æ¬çºæã®LCGã®è£œé ã«ãããŠã¯ãé©åœãª
ã³ã©ãŒã²ã³ã®æžæ¿æ¶²ãæ¿åºŠçŽ20ã100mgïŒml
ãšããŠæ³šåããããã·ãŒãç¶ã«æŒåºæ圢ã
ãããããã®æ圢äœãç¶ããŠçŽâ10ãâ50â
ã§åçµåŸã³ã³ãã³ãµãŒæž©åºŠçŽâ45ãâ55âã
ã·ãšã«ã枩床çŽâ30âãšããŠçŽ10ã
100millitorrã§åçµä¹Ÿç¥ãããïŒãïŒæ¥éå
çµä¹Ÿç¥åŸã·ãšã«ã枩床ã15ã25âã«äžæãã
ããã«24æéåŸã«åçµä¹Ÿç¥åšããLCGãå
ãåºãã å¥æ³ãšããŠãå¯æº¶å圢ã®ç²Ÿè£œã³ã©ãŒã²ã³ã
çšããããšãã§ããããã®æ§ãªæº¶æ¶²ã¯ç²Ÿè£œã¢
ããããããã³ã©ãŒã²ã³ãçŽPHïŒãïŒã§æ°Žæº¶
液äžã«æº¶è§£ããéæ埮现ãéã§æ» èåŸãäŸã
ã°ãªã³é žå¡©ç·©è¡æ¶²ãçšããŠPHãã»ãŒäžæ§ãšã
åæ§æ圢æ ãæ²æŸ±ãããŠè£œé ãããçæãã
æ²æŸ±ã³ã©ãŒã²ã³ãé å¿åé¢æ³ã§æ¡éãããã¬
ããåããã³ã©ãŒã²ã³ãäžæ§ã®ç·©è¡æ¶²äžã«å
æžæ¿ãããŠåè¿°ã®ããã«åŠçããã ç¹å®ã®çšéã«ãããŠããåªããçµæãåŸã
ãããåè¿°ã®æ¹æ³ã®æ¹è¯æ¹æ³ã«çžåœããå¥ã®
åçµä¹Ÿç¥æ¹æ³ããããã³ã©ãŒã²ã³æžæ¿æ¶²ãæ»
èããå¹é€æ¿ïŒäŸãã°ã35mmïŒäžã«æ³šåãã
åŸããã泚åäœãã¹ãããŠã©çã§å¹³æ»ã«ã
ãã次ãã§ãã®æ³šåäœãåçµãçŽâ100ãâ
50âã奜ãŸããã¯çŽâ80âã«ïŒæéä¿æåŸå
çµä¹Ÿç¥ãããçŽ10ã100millitorrçŽ24æéå
çµä¹Ÿç¥ããŠä¹Ÿç¥ãããåãæ°mmã®å€å質ã®ã
ãããåŸãã 骚起æºã³ã©ãŒã²ã³ æ¬çºæã§çšãã骚ã³ã©ãŒã²ã³ç²æ«ïŒBCPïŒ
ã¯ç¡æ©æåãé€å»ãã骚ããåŸããã®ã§ãåŸ
ã€ãŠãã®ã³ã©ãŒã²ã³æåã¯å°ãåã³ã©ãŒã²
ã³ã§ããããã®ã³ã©ãŒã²ã³è£œå€ã¯åŸæ¥æ§é ã
ãã圢æ ã®ã³ã©ãŒã²ã³ãšã¯ç©ççãååŠçç¹
æ§ãç°ãªãæ°ç©è³ªã§ããã也ç¥ç²æ«ç¶ã§äŸ¿å©
ã«è²¯èµããããšãã§ãããéåžžãçãè±çã®
åºä¹³åç©ã®éªšã奜ãŸããã¯ç·»å¯ãªéªšãæŽæµã
åçµãç²ç åŸãåžžæ³ãçšããŠã¯å¡©é žçã®é©åœ
ãªé žã§ç¡æ©ç©ãé€å»ãããæ®åææ©ç©ãåé¢
ããèçœè³ªåè§£é µçŽ ãé次çã«ãããã¯çµã¿
åãããŠäœ¿çšããŠæ¶åããããªãªããŒãšã°ã©
ã³ãïŒOliverãGrantãè±åœç¹èš±ã
GB1565340AïŒãèšèŒããæ§ã«ãéã³ã©ãŒã²
ã³è³ªã®èçœãéžæçã«å£åãããããªãã·ã³
çã®äžæ§èçœè³ªåè§£é µçŽ ã奜ãŸãããããã·
ã³çã®ç¹å®ã®é žæ§èçœè³ªåè§£é µçŽ ã¯ã³ã©ãŒã²
ã³ãéšåçã«æ¶åããã®ã§å¥œãŸãããªããé
èçœæ§ã®éªšæåãã³ã³ããã€ãããŒãŒããã¢
ã«ããããŒãŒãåã³çš®ã ã®ãã¯ã¬ã¢ãŒãŒçã®
é©åœãªé µçŽ ãçšããŠé€å»ã§ããããã¡ããã³
ã©ã²ããŒãŒã®äœ¿çšã¯äžé©åœã§ãããé©åœãªé µ
çŽ ã䜿çšããŠåŠçããåŸã®äžæº¶æ§ç©è³ªã¯
BCP圢ã®ç²Ÿè£œã¢ããããããããæããã
ãã¯Î³ç·ç §å°åã¯å ç±çã®æ¢ç¥ã®æ¹æ³ã§æ» è
åŸäœ¿çšããããšãã§ãããããªãã·ã³åŠçåŸ
ã«æ®åããå šãŠã®ããããããã®æ®åæåæ§
å¹æãç·©åãããã®ã§ããã®åã®ã³ã©ãŒã²ã³
ã§ã®æ¶æ©ã®ååšã¯å¥œãŸããå Žåãå€ãã ãã®æ§ã«ããŠåŸãBCPã¯æ°èŠãªãã®ã§ã
ããããã¯æ¬è³ªçã«åã³ã©ãŒã²ã³ããæ
ããèŠæãäžã骚ã³ã©ãŒã²ã³ã®å ã®ååæ§é
ãä¿æããŠããããããããããã¯å«ãŸãª
ãã ãã®BCPã¯ãé©åœã«ååŠçãã骚ã®æ¬ é¥
äžã«å§å ¥ããŠäœ¿çšããããã«çççç·©è¡æ¶²äž
ã«åæžæ¿ããã æ··åç© æ··åç©ã䜿ã€ãŠæ¬çºæã®ç§»æ€çåã¯ããŒã¹
ãç¶ä¿®åŸ©ææã補é ããå Žåã¯ãææã®åã
æ±ãäžã®å¿ èŠæ§åã³ä¿®åŸ©éšäœã«ãããããšã
äºæ³ãããå¿åã«å¯ŸåŠããã®ã«å¿ èŠãªç©æ§ã«
å¿ããæ¯çç¯å²ã®ãZCIçã®åæ§æ埮ç¹ç¶ç¶
ã¢ããããããã³ã©ãŒã²ã³ã®æžæ¿æ¶²åã³
BCPã䜿ã€ãŠè£œé ãããBCPéãå¢ããšçµ
æç©ã«èééæ§åã³èå¿åæ§ãä»äžããããš
ãã§ããã®ã«å¯ŸããŠãZCIã«å¯ŸããBCPæ¯ç
ãæžãããšæè»æ§ãå¢ãé©çšæ§ãè¯ããªãã
åŸã€ãŠæ¬çºæã®æ¹æ³ã¯ãåŸæ¥æ¹æ³ã«æ¯èŒããŠ
çäœã®æ¬ é¥ã修埩ããéããã®æ§è³ªã«å¿ããŠ
極ããŠé å¿æ§ã«å¯ãã æ¯çã®ç¯å²ã¯ãã¡ããããããã®æåãå
ç¬ã§äœ¿çšã§ããã»ã©å€§ããã奜é©ãªæ··åç©ã¯
æ¬ é¥ã®æ§è³ªã«ããã®ã§ãäžè¬çã«å¥œãŸããå
äžã®ç¯å²ã¯ç¹å®ã§ããªããã ããäžè¬çã«
ã¯ãééããããæ¬ é¥éšã«å¯ŸããŠã¯çŽ50ïŒ
ZCIïŒ50ïŒ BCPãçŽ10ïŒ ZCIïŒ90ïŒ BCPïŒé
éïŒ ïŒã®ç¯å²ã奜ãŸãããæ¯æ ¹èåã¯è¡šé¢éš
ã®æ¬ é¥ã«å¯ŸããŠã¯çŽ90ïŒ ZCIïŒ10ïŒ BCPãçŽ
50ïŒ ZCIïŒ50ïŒ BCPïŒééïŒ ïŒã奜ãŸããã
ïŒäžèšã®æ¯çã¯ZCIã®35mgïŒmlæžæ¿æ¶²ãæ³å®
ãããã®ã§ãééã¯å šæžæ¿æ¶²ã®ééãèšãïŒã  å®æœäŸ 以äžã«æ¬çºæã説æããããããã¯æ¬çºæãé
å®ããããšãããã®ã§ã¯ãªãã C.1 ZCIè£œå€ ã¶ã€ããŒã ã»ã³ã©ãŒã²ã³ç§»æ€ç©ïŒCollagen
Corporationãã«ãªããªã«ãã¢å·ãããã¢ã«ã
ããè³Œå ¥ïŒãåæ§æ埮ç¹ç¶ç¶ã¢ããããããæ
åãšããŠäœ¿çšãããåæ§æ倩ç¶åã³ã©ãŒã²ã³åŸ®
ç¹ç¶ãæ¿åºŠçŽ35mgïŒmlã§çšããããã®è£œå€ã¯å
å·¥æã«ãéããŠæ» èããã®ã§ãå ç±åã¯ç §å°ç
ã®å£åã被ããå·¥çšã¯åããŠããªãã C.2 ICGè£œå€ ïŒ¡ 埮现ãéã§æ» èããçŽPHïŒãïŒã®ããã·ã³
å¯æº¶åçç®ã³ã©ãŒã²ã³æ°Žæº¶æ¶²ããªã³é žå¡©ç·©è¡æ¶²
ã§PH7.4ã«èª¿ç¯ãããæ²æŸ±ããã³ã©ãŒã²ã³ãé
å¿åé¢ããŠæéåŸãPH7.4ã®ãªã³é žå¡©ç·©è¡æ¶²äž
ã«æ¿åºŠ35mgïŒmlã§æžæ¿ããããæžæ¿æ¶²ãã·ãŒã
ç¶ã«æ³šåãããã®ã·ãŒããâ25âã§åçµåŸã³ã³
ãã³ãµãŒæž©åºŠâ50âã25millitorrã§åçµä¹Ÿç¥ã
ããåçµä¹Ÿç¥ããã·ãŒããâ30âã§ïŒæ¥é貯èµ
åŸã枩床ãåã³20âã«äžã䜿çšçŽåã®24æéä¿
æããã  å¥æ³ïŒæãã¯æ¹è¯æ³ïŒãšããŠãçŽïŒc.c.ã®ã¶
ã€ããŒã ã»ã³ã©ãŒã²ã³ç§»æ€ç©ïŒã€ã³ãã©ã³ãïŒ
ãæ» èãã35mmçµç¹å¹é€æ¿äžã«æ³šåããã¹ãã
ãŠã©ã§å¹³æ»åããããã®ã³ã©ãŒã²ã³ã²ã«ãåçµ
ããâ80âã«çŽïŒæéä¿æãããç¶ããŠã³ã©ãŒ
ã²ã³ã²ã«ã也ç¥ãããŸã§çŽ24æéåçµä¹Ÿç¥ãã
çŽåŸ35mmãå§ãïŒãïŒmmã®å€å質çœè²ãã€ã¹ã¯
ãåŸãã C.3 BCP補å€ïŒçïŒ çã®å€§è ¿éªšãææŽãããŠä»çããè»éšçµç¹ã
é€ãã骚ã®é¢ç¯ç«¯ã骚端æ¿è¿ãã§é€å»ããŠæ¬è³ª
çã«ç·»å¯ãªéªšãåŸãã骚幹ã液äœçªçŽ ïŒLN2ïŒ
ã§å·åŽãã軞æ¹åã«å²ã€ãŠéªšé«ãåãé€ããã
ç·»å¯ãªéªšçãLN2枩床ã§ãžãšãŒã¯ã©ãã·ã€ãŒã
䜿ã€ãŠç²åŸïŒmm以äžã®ç Žçã«ç Žç ããããã®éªš
çããã³ããŒãã«ã䜿ãããã¯ãLN2枩床ã§ç²
ç ããã 骚ç²ãæµæ°Žäžã§ãµãã€ãŠã125ã250ÎŒïœãš
250ã450ÎŒïœã®ïŒã€ã®ç²åŸéšåã«åããããã®
ïŒçš®é¡ã®ç²åŸéšåãå¹³è¡ããŠãåå¥ã«å å·¥ã
ãã 0.5M HClãçšãïŒéªšç²ïŒïœã«å¯ŸããŠHCl溶
液25mlïŒïŒã1.5æéåŸã«æ°ããé žãšäº€æããŠã
宀枩äžïŒæéãããŠéªšç²ããç¡æ©æåãé€å»ã
ããç¡æ©æåé€å»å·¥çšã®çµãã«ã骚ç²ãïŒåæ°Ž
æŽãé žæº¶æ§ç¡æ©ç©ãé€å»ãããç¡æ©ç©ãé€å»ã
ã骚ç²ããèçœè³ªå解åŠçã«å ç«ã€ãŠåçµä¹Ÿç¥
ããã åçµä¹Ÿç¥ãã骚ç²ãããªãã·ã³ã§æ¶åãã
ïŒ0.5mgïŒml NaN3ãå«ã0.1M Na2HPO4 ïŒ
mlåœã骚ç²50mgåã³ããªãã·ã³ïŒmgïŒããªãã¡
ããªãã·ã³ïŒéªšç²ïŒïŒïŒ25ïŒãé µçŽ ã«ããæ¶å
ã15âã§10æ¥éè¡ã€ããæ¶åäžæŸæ¶²ãããŠã¬ã
ãæ³ã§å 溶æ§èçœè³ªã«ã€ããŠåæããæ¶åã®é²
è¡ãç£èŠããã ããªãã·ã³æ¶åçæç©ãé€ãããã骚ç²ãæ²
éãããŠããäžæŸã¿æ¶²ãåé¢ããåºäœåã«4M
NaCl溶液ïŒ10ïŒïŒïŒå®¹ç©ïŒééïŒãå ããã
骚ç²ã宀枩ã§ïŒæéæ¹æãããã®æç¹ã§ç²æ«ã
æ²éãããŠãã«ã³ããŒã·ãšã³ããã4M NaCl
ã«ããæœåºãåèšïŒåç¹°ãè¿ããã å¡©åãããªãŠã ãé€ãããã10åéã®ç±³åœè¬
å±æ¹æ³šå°çšæ°ŽïŒWFIïŒäžã§NaClæœåºã«ã€ããŠ
ã®èšèŒãšåæ§ã«ããŠ10åéæ¹æããŠïŒåæŽæµã
ãã 次ãã§éªšç²ã10åéã®ã¢ã»ãã³ã§ïŒåæœåºã
ååšããå šãŠã®è質ãé€å»ãããã¢ã»ãã³æœåº
åŸã骚ç²ãWFIã§ïŒåæŽæµããç空ãéããŠ
ããåçµä¹Ÿç¥ããŠéªšã³ã©ãŒã²ã³ç²æ«ïŒBCPïŒ
ãåŸãã BCPè©Šæãè質ãã°ãªã³ã¹ã¢ããã°ãªã«ã³
ïŒglycosaminoâglycanïŒãåã³ã¢ããé žçµæç©
ã«ã€ããŠååŠçã«ãæ®åããªãã·ã³ãçèµ€è¡ç
现èãåã³çã³ã©ãŒã²ã³ããããããïŒã³ã©ãŒ
ã²ã³ã®æåæ§ç«¯æ«ïŒã«ã€ããŠå ç«åŠçã«ããã
ã«è¶ 埮现æ§é ã«ã€ããŠé»åé¡åŸ®é¡çã«åæã
ããããªãã·ã³åŠçãé²ãã«ã€ããŠã奜ãŸãã
ã¯ïŒã10æ¥ã§ãBCPã¯æ¬¡ç¬¬ã«ããããããã
ã»ãšãã©å«ãŸãªãçŽç²ã®åçã³ã©ãŒã²ã³ã«ãª
ã€ããé»åé¡åŸ®é¡ã«ãããç¹åŸŽçãªåž¯ç¶ããªã
ã³ã©ãŒã²ã³åŸ®ç¹ç¶ãšç骚ã®çµç¹ãèªããããã
ãŸããã¢ããé žçµæãããååŠçã«çŽç²ãªã³ã©
ãŒã²ã³ã§ããããšãå€ã€ãã ãã®æ§ã«ããŠè£œé ããBCPã«ã¯ïŒçš®é¡ã«ã®
ç²åŸããããããã«ç¬¬ïŒè¡šã«ç€ºãããã«ããªã
ã·ã³åŠç床åã®ç°ãªããã®ããã€ããå šãŠã®è©Š
æã¯1.5Mradã§Î³ç·ç §å°ããŠæ» èããã ãè¡šã C.4 BCPãZCIæ··åè£œå€ åé ã§2Cåã³3Cãšåœåãã骚ã³ã©ãŒã²ã³ç²
æ«ïŒBCPïŒã55ïŒ45ïŒééæ¯ïŒã§æ··åãã
1.5Mradã§Î³ç·ç §å°ããŠæ» èããã ãã®æ» èBCPæ··åç©ã䜿ã€ãŠïŒãããã®
BCPïŒZCIæ··åç©ã補é ãããããªãã¡ã也ç¥
BCP0.33ïœãZCIïŒ35mgïŒmlã®æžæ¿æ¶²ãã€ãŸã
åºäœåçŽ0.67ïœïŒ0.035ïœïŒmlãšããŠïŒ0.67ïœãš
æ··åãZCIã®33ïŒ BCPæ··åç©ã調補ããããŸ
ããBCP0.17ïœãZCIïŒ35mgïŒmlæžæ¿æ¶²ïŒ0.83ïœ
ãšæ··åããŠç¬¬ïŒã®æ··åç©ã調補ããããããã®
ææãããããååã«æ··åããŠïŒã1/4c.c.ã®æ³š
å°åšã«æºããã以äžã®æé ã«çšããã C.5 ZCIã«ãã骚ã®æ¬ é¥ã®ä¿®åŸ© çåŸïŒãïŒé±éã®45å¹ã®ã©ããã«éº»é ãã
ããé ç®ãå転ããŠé è骚èãé€å»ãããæ¯ç§
çšããªã«ã䜿ã€ãŠé èåŽå£éªšã«ïŒÃïŒmmã®è²«é
æ¬ é¥ãå·Šå³å¯Ÿç§°ã«èšãããC.1ã«èšèŒããæ³šå ¥
å¯èœãªã³ã©ãŒã²ã³ã²ã«ãå°åã¹ãããŠã©ã䜿ã€
ãŠæ¬ é¥äžã«å å¡«ããé ç®ãå ã«æ»ããŠçž«åã
ããæ¬ é¥å ã®çåé床ã移æ€åŸïŒãïŒãïŒåã³
16é±éåŸã«ïŒžç·äžŠã³ã«çµç¹åŠçã«ç£èŠããã ïŒé±éåŸã«ã¯ã³ã©ãŒã²ã³ã²ã«å ã«çµç¹åŠçã«
æ°ãã骚现èïŒéªšèœçŽ°èïŒã®å³¶ãšåºè³ªãèªãã
ãããïŒé±éåŸãŸã§ã«ã¯å€§åã®äºäŸã§æ°ãã骚
ãæ¬ é¥å šäœã«åºãããæ¬ é¥ã®åæ端éšéã®èå
ç©åã³ãã®æ°ãã骚ãçãå§ãããïŒã16é±é
ã®éã«ãæ°æ§ã®éªšã®çµåéšãã»ãšãã©èŠåãã
ããªããªã€ãããŸããæ°ãã骚ã¯åæ§æãã
ãŠãæ¬ é¥éšã«å ããååšãã骚ã«å žåçãªæç
ãªéªšé«è ãæããç·»å¯ãªéªšã®å±€ãšãªã€ããã©ã
ãããé€ãå»ã€ãé èã®ïŒžç·ããã16é±éåŸã®
æ¬ é¥äžã«å€éã®ïŒžç·äžééæ§ã®éªšã®ååšã確èª
ãããã移æ€ããŠããªãå·Šå³å¯Ÿç§°ã®é èåŽå£éªš
æ¬ é¥ãæããã©ããã§ã¯èŠ³å¯æé16é±éã§ã¯é¡
èãªçåã¯èªããããªãã€ããåŸè ã®å Žåã骚
圢æ掻åã¯æ¬ é¥ã®åæ端ã®å°éšåã«éå®ããã
æ¬ é¥ã®æ®éšã¯ãããçµåçµç¹ã§æºããããŠã
ãã ãã®æ§ã«ãåæ§æã³ã©ãŒã²ã³ç¹ç¶ã«ãã€ãŠã
äŒå°éªšçé·ã®æ¯æåºè³ªãæäŸããããã®æ°èŠã§
æçšãªæ¹æ³ãåŸãããã C.6 LCGãçšããé èæ¬ é¥ã®ä¿®åŸ© çåŸçŽïŒé±éã®ã©ããã«éº»é ãæœããé ç®ã
å転ããŠé è骚èãé€å»ãããæ¯ç§çšããªã«ã
䜿ã€ãŠé èåŽå£ã®éªšã«ïŒÃïŒmmã®è²«éæ¬ é¥ãå·Š
å³å¯Ÿç§°ã«èšãããC.2Bã«æºããŠè£œé ããåçµ
也ç¥ã³ã©ãŒã²ã³ãæ¬ é¥ããè¥å¹²å€§ããã®çŽ°çç¶
ã«åæãã移æ€çãæ¬ é¥éšã«ãã€ããå°å ¥ãã
ãããã«ãããäžéšã®çŽ°çã¯æ¬ é¥äžã«ä¹Ÿç¥ç¶æ
ã§å ¥ããã®äžã§æ°Žåãããããäžéšã¯ç§»æ€ã«å
ç«ã€ãŠæ°Žåãããã移æ€åŸãé ç®ãå ã«æ»ããŠ
çž«åãããæ¬ é¥å éšã®çåé床ãã移æ€ïŒåã³
ïŒé±éåŸã«çµç¹åŠçã«è©äŸ¡ããã ïŒé±éåŸã«ã¯ç§»æ€çäžã«çµåçµç¹åã³è¡ç®¡ã
åå浞最ããããæ°ãã骚ã®åœ¢æã¯æ¥µããŠéå®
ãããŠãããåé ã«èšèŒããåã®é移æ€æ¬ é¥ã¯
çåããè»éšçµç¹ã§æºãããããŸãŸã ã€ããã
修埩ããæ¬ é¥ã§ã¯28æ¥åŸãŸã§ã«ã¯ç§»æ€çå šäœã«
æ°ãã骚ã®åœ¢æãèªããããããŸããæ¬ é¥ã®å
æ端éšãšç§»æ€çã®çé¢ã«æ©ããæ¢åã®éªšãšã®è
åã®åŸŽåãèªããããã56æ¥åŸãŸã§ã«ã¯ãæç
ãªéªšé«è ãæããæçãã骚ã®ååšãæ¬ é¥å šäœ
ã«èªããããã LCGã¯å®¹æã«åæããŠãäŒå°éªšçé·ãæ¯æ
å¯èœãªæ¿å ¥ç©ãæ圢ããããšãã§ãããåŸãã
ãåçµä¹Ÿç¥åæ§æã³ã©ãŒã²ã³ç¹ç¶ã®ãããã¯ã
ã®ç®çã«å¥œé©ãªææã§ããã C.7 骚ã®ä¿®åŸ©ãžã®BCPã®äœ¿çš çåŸïŒé±éã®ã©ããã«éº»é ãæœããé èã®å·Š
å³ã®å£éªšã«ïŒÃïŒmmã®æ¬ é¥ãèšãããæ¯ç§çšã
ãªã«ã§é èã«è²«éåãéããåè¿°ã®æ§ã«ããŠèª¿
補ããBCPãæ» èé£å¡©æ°Žã§æ¹¿æœ€åŸæ¬ é¥ã«å å¡«
ãããå¯Ÿç §çšæ¬ é¥ã¯æªå å¡«ã®ãŸãŸæ®ãããåèš
第ïŒè¡šã®BCPè©Šæ2Bã3Zã3Aã3Bãåã³3C
ãè©Šéšããã移æ€åŸïŒåã³ïŒé±éåŸã«è©Šæãæ¡
åããçµç¹åŠçã«æ€æ»ããã è©Šæ3ZïŒããªãã·ã³æ¶åå®æœããïŒåã³3A
ïŒããªãã·ã³æ¶åïŒæ¥ïŒã¯æåæ§æåã®èšŒæ ã
䌎ãççã瀺ãããè©Šæ2Bã3Bãåã³3Cã¯ïŒ
é±éã§å€æ žæ§çŽ°èåå¿ã骚èœçŽ°èåå¿ã䌎ã
BCPã®æ¶åã䞊ã³ã«æ°ããç·»å¯ãªéªšã®æ²çã
瀺ãããïŒé±éã®æç¹ã§ã移æ€çå šäœã«å€éã®
骚ã圢æãããæ°æ§éªšã®èåã®åŸŽåãèªããã
ããå¯Ÿç §æ¬ é¥ã«ã¯åæ端éšã§å ããªéªšã®çé·ã
èªããããã«éããªãã€ãã BCPè©Šæ3Zã移æ€ããã©ããã®è¡æž äžã«ã¯
BCPã«å¯Ÿãã埪ç°æäœãååšãããè©Šéšãã
ä»ã®BCPè©Šæã¯æäœåå¿ãèªçºããªãã€ãã ãããã®çµæã第ïŒè¡šã«èŠçŽããŠç€ºãã ãè¡šã C.8 BCPã®å ç«åæ§åå¿ã«ã€ããŠã®è ¹èæœ æµå
æ BCPè©Šæ2Zã2Aã2Bãåã³3Bã30mgããª
ã³é žå¡©ã§ç·©è¡ããé£å¡©æ°ŽïŒPBSïŒïŒmlã«æžæ¿
ãããã©ããã®è ¹è å ã«æ³šå ¥ãããïŒãïŒã
14ãåã³28æ¥åŸã«è ¹è ãPBS100mlã§æœ æµããŠ
现èãéžå¥èšæ°åã³å šæ°èšæ°ããççã®å®éç
尺床ãšããããŸããBCP移æ€çãçµç¹åŠçã«
æ€æ»ããè¡æž ã埪ç°æäœã®å°ºåºŠãšããã å šè©Šæã§ïŒæ¥åŸã«é·ç§»çãªå¥œäžçåå¿ãèªã
ããããã®ææã«ç¹ç°çãªæ§è³ªã«é¢é£ãããã®
ãšèãããããïŒã14ãåã³28æ¥ã®æç¹ã§ã¯å¿
ç现èã¯ãã€ã¯ããã¢ãŒãžãæ¯é çã«ãªãã移
æ€çã®çµç¹åŠçæ€æ»ã«ããã°28æ¥åŸã«ãããŠæ
ããã«å€éã®BCPã®æ¶åãèªããããã極ã
埮éã®å ç«æ§çŽ°èïŒãªã³ãçïŒãåžžæååšã
ããè¡æž åŠæ€æ»ã®çµæã2Zã移æ€ããã©ãã
ã§BCPã«å¯Ÿããæäœã®æ»Žå®éãããªãã®éã«
éããããšãå€ã€ãã2Aã2Bã2Cãåã¯3B
ã移æ€ããã©ããã§ã¯æäœåå¿ãçºçŸããªãã€
ãã BCPã¯äŒå°æ©æ§ã§ã®éªšã®ä¿®åŸ©ã«æçšãªã骚
ãåæãšããæ°èŠãªåºæã§ããã骚ã³ã©ãŒã²ã³
ç²æ«ïŒBCPïŒã¯éªšã®æ¬ é¥éšã®åœ¢ç¶ã«ããããš
ãã§ããæéžãã骚ã®èå¿åæ§ã®è£å¡«ç©ã§ãæ°
ãã骚ã®çé·ãæ¯æããã C.9 骚ã®ä¿®åŸ©ãžã®BCPïŒZCIæ··åç©ã®äœ¿çš çåŸïŒãïŒé±éã®ã©ãã24å¹ã«éº»é ãæœãã
é èã®å·Šå³ã®åŽéªšã«ïŒÃïŒmmã®æ¬ é¥ãèšããã
æ¯ç§çšããªã«ã䜿ã€ãŠé èã«è²«éåãèšããå
èšã®æ§ã«ããŠè£œé ããïŒçš®é¡ã®BCPïŒZCIæ··å
ç©ãåäžã«å å¡«ãããå¯Ÿç §æ¬ é¥ã«ã¯BCPåã¯
ZCIåäœãå å¡«ãããæªå å¡«ãšããã移æ€åŸïŒ
åã³ïŒé±éåŸã«è©Šæãæ¡åãçµç¹åŠçã«æ€æ»ã
ãã BCPïŒZCIæ··åç©ãå å¡«ããæ¬ é¥ã§ã¯ç§»æ€åŸ
ïŒé±éã§æ®éãããæ©ã骚ã®çé·ãçãããã
ããBCPïŒZCIæ··åç©ã¯å¿ ãããåäžã§ãªãã
ããæ¬ é¥ã®ç¹å®éšäœã«ååšããã³ã©ãŒã²ã³è³ªç§»
æ€çäžã®æ¯é çš®ïŒã€ãŸããBCPåã¯ZCIïŒã«ã
ã€ãŠéªšã®åœ¢æãã¿ãŒã³ãå€åããã ïŒé±éç®ãŸã§ã«ã¯BCPïŒZCIæ··åç©ã®ZCIæ
åäžã§æ°ãã骚ãå€éã«åœ¢æãããBCPç²å
ã¯æ°ãã骚圢æ§æŽ»æ§ã®äžå¿éšã«åã蟌ãŸãã€ã€
ãã€ãããããæ©æã®åæ§æãšçžä¿ã€ãŠãæ¬ é¥
éšã«åºããæ°ãã骚ã®å€èŠ³ã14æ¥ã®æç¹ããã
åäžæ§ã垯ã³ãŠããã移æ€ããå¯Ÿç §æ¬ é¥ïŒã€ãŸ
ããBCPåç¬åã³ZCIåç¬ïŒã«ã¯äžè¿°ã®ç 究ã§
芳å¯ãããç¹åŸŽçãªåœ¢åŒã®éªšçºç掻æ§ãèªãã
ããã移æ€ããªãã€ãå¯Ÿç §æ¬ é¥ã§ã¯æ¬ é¥ã®åæ
端éšã«å ããªéªšã®çé·ãèªããããã«éããªã
ã€ãã 匟æ§ã®ã²ã«ç¶æžæ¿ç©ã圢æãã粟補ã¢ããã
ãããåæ§æ埮ç¹ç¶ç¶ã³ã©ãŒã²ã³ãšå§çž®åŒ·åºŠã
ä»äžãã骚ã³ã©ãŒã²ã³ç²æ«ãšã®çžå¯Ÿéãå€ãã
ããšã«ãã€ãŠãäŒå°ã«ãã骚ã®ä¿®åŸ©ã«é©ããåº
質ãåŸãäžã§ãå€æ§æ§ã«å¯ãæçšãªç§»æ€ææã
補é ã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ (i) ç¡æ©æåãé€å»ãã骚起æºã®ã³ã©ãŒã²ã³
ã®ç²Ÿè£œã¢ãããããã補å€ããæã骚ã³ã©ãŒã²
ã³ç²æ«ã (ii) 粟補ã¢ããããããåæ§æ埮ç¹ç¶ç¶ç®èã³ã©
ãŒã²ã³ã (iii) 粟補ã¢ããããããåæ§æ埮ç¹ç¶ç¶ç®èã³ã©
ãŒã²ã³ã®åçµä¹Ÿç¥ã²ã«ãåã³ (iv) (i)åã³(ii)ã®æ··åç© ããæãã°ã«ãŒãããéžæãããäžã€ããæãã
ãšãç¹åŸŽãšãã骚ã®æ¬ é¥äžã«å å¡«ããŠæ°é®®ãªéªšãš
æ¥è§Šãããããã®åºä¹³åç©ã®éªšã®æ¬ é¥ã®äŒå°ä¿®åŸ©
çšã³ã©ãŒã²ã³è£œå€ã ïŒ åèš(ii)åã³(iii)ã®ã³ã©ãŒã²ã³è£œå€ãåçã®ç®è
ãã補é ããããšãç¹åŸŽãšããè«æ±ã®ç¯å²ç¬¬ïŒé
ã«èšèŒã®è£œå€ã ïŒ åèš(iii)ã®ã³ã©ãŒã²ã³è£œå€ããããç¶ã«æŒåºæ
圢ããããšãç¹åŸŽãšããè«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒ
ã®è£œå€ã ïŒ åèš(ii)åã³(iii)ã®ã³ã©ãŒã²ã³è£œå€ãå®è³ªçã«æ¶
æ©ããŠããªãããšãç¹åŸŽãšããè«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®è£œå€ã ïŒ åèšç²Ÿè£œã¢ããããããåæ§æ埮ç¹ç¶ç¶ç®è
ã³ã©ãŒã²ã³ã®åçµä¹Ÿç¥ã²ã«ã¯ãæžæ¿æ¶²ããåçµä¹Ÿ
ç¥ãã粟補ã¢ããããããåæ§æ埮ç¹ç¶ç¶ç®èã³
ã©ãŒã²ã³è£œå€ããå®è³ªçã«æãåæ§æã³ã©ãŒã²ã³
ç¹ç¶ã®åçµä¹Ÿç¥ãããã§ããããšãç¹åŸŽãšããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ã³ã©ãŒã²ã³è£œå€ã ïŒ åèšã³ã©ãŒã²ã³ãå®è³ªçã«æ¶æ©ããŠããªãã
ãšãç¹åŸŽãšããè«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ã³ã©ãŒ
ã²ã³è£œå€ã ïŒ åèšåçµä¹Ÿç¥ãããã¯ã (a) 粟補ã¢ããããããåæ§æ埮ç¹ç¶ç¶ç®èã³ã©
ãŒã²ã³ã®æžæ¿æ¶²ãæ¿ç¶ã«æ³šåãã (b) 泚åçæç©ãåçµä¹Ÿç¥ããå·¥çšããæã骚移
æ€çãšããŠã®äœ¿çšã«é©ããåçµä¹Ÿç¥ã³ã©ãŒã²ã³
ãããã§ããããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²
第ïŒé ã«èšèŒã®ã³ã©ãŒã²ã³è£œå€ã ïŒ åèšéªšã³ã©ãŒã²ã³ç²æ«ã¯ãå®è³ªçã«éªšã³ã©ãŒ
ã²ã³ç²æ«ããæãããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé èšèŒã®ç²Ÿè£œã³ã©ãŒã²ã³è£œå€ã ïŒ åèšéªšã³ã©ãŒã²ã³ç²æ«ã¯ãç¡æ©æåãé€å»ã
ã骚ç²ãããªãã·ã³åã³ããã·ã³ããéžã°ããå°
ãªããšãäžçš®é¡ã®èçœè³ªåè§£é µçŽ ã§åŠçããã骚
ã®æ¬ é¥ã®ä¿®åŸ©ãžã®äœ¿çšã«é©ãã骚ã³ã©ãŒã²ã³ç²æ«
ã§ããããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé å
ã¯ç¬¬ïŒé èšèŒã®ã³ã©ãŒã²ã³è£œå€ã
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62832884A | 1984-07-06 | 1984-07-06 | |
| US628335 | 1984-07-06 | ||
| US628409 | 1984-07-06 | ||
| US628404 | 1984-07-06 | ||
| US628328 | 1984-07-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6162459A JPS6162459A (ja) | 1986-03-31 |
| JPH0326616B2 true JPH0326616B2 (ja) | 1991-04-11 |
Family
ID=24518429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60149101A Granted JPS6162459A (ja) | 1984-07-06 | 1985-07-06 | 骚ã®ä¿®åŸ©çšã³ã©ãŒã²ã³è£œå€ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6162459A (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4975526A (en) * | 1989-02-23 | 1990-12-04 | Creative Biomolecules, Inc. | Bone collagen matrix for zenogenic implants |
| US7083820B2 (en) * | 2000-09-29 | 2006-08-01 | Schilling Marvin L | Method for producing biologically active products |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5584161A (en) * | 1978-12-16 | 1980-06-25 | Intermedicat Gmbh | Bone substance substitute |
| JPS55155643A (en) * | 1979-05-23 | 1980-12-04 | Koken Kk | Artificial bone and its preparation |
-
1985
- 1985-07-06 JP JP60149101A patent/JPS6162459A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5584161A (en) * | 1978-12-16 | 1980-06-25 | Intermedicat Gmbh | Bone substance substitute |
| JPS55155643A (en) * | 1979-05-23 | 1980-12-04 | Koken Kk | Artificial bone and its preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6162459A (ja) | 1986-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4789663A (en) | Methods of bone repair using collagen | |
| CA1259914A (en) | Methods of bone repair using collagen | |
| RU2104703C1 (ru) | СпПÑПб пПлÑÑÐµÐœÐžÑ ÐŒÐ°ÑеÑОала ÐŽÐ»Ñ ÐŸÑÑеПплаÑÑОкО О пПлÑÑеММÑй ÑÑОЌ ÑпПÑПбПЌ ЌаÑеÑОал | |
| US6576015B2 (en) | Bone material and collagen combination for repair of injured joints | |
| US7186811B2 (en) | Osteogenic device and a method for preparing the device | |
| JP4020962B2 (ja) | 骚移æ€çµæç© | |
| EP0810888B1 (en) | Resorbable extracellular matrix for reconstruction of cartilage tissue | |
| US6180606B1 (en) | Compositions with enhanced osteogenic potential, methods for making the same and uses thereof | |
| AU671721B2 (en) | Tgf-beta formulation for inducing bone growth | |
| JPH03504736A (ja) | 移æ€çšéªšã³ã©ãŒã²ã³ãããªãã¯ã¹ | |
| JP2010075718A (ja) | 骚ã®åæ§æçšã®ååžåæ§çŽ°èå€ãããªãã¯ã¹ | |
| JPH0430867B2 (ja) | ||
| US8858981B2 (en) | Bone healing material comprising matrix carrying bone-forming cells | |
| AU593094B2 (en) | Marrow/collagen/mineral matrix for bone defect repair | |
| US5138030A (en) | Process for extracting type I collagen form an avian source, and applications therefor | |
| US20070020245A1 (en) | Composition for the treatment of arthrosis/arthritis, especially for treating joints | |
| JPH0326616B2 (ja) | ||
| KR20050023298A (ko) | ìŒëŒíŽ ì ëì ì íìžê³Œ ì¬ë£ | |
| JPH06343687A (ja) | 现èäŸµå ¥æ§éªšä¿®åŸ©æ | |
| AU2012200086A1 (en) | Resorbable Extracellular Matrix for Reconstruction of Bone |